Skip to content
Home
Healthcare provider image placeholder

Michael P. McDermott, Ph.D.

About Me

Faculty Appointments

Professor - Department of Biostatistics and Computational Biology (SMD)

Associate Chair - Department of Biostatistics and Computational Biology (SMD)

Professor - Center for Health and Technology - Joint

Professor - Department of Neurology (SMD) - Joint

Credentials

Education

Ph.D. | University of Rochester. Statistics. 1989

M.A. | University of Rochester. Statistics. 1985

B.A. | Boston College. Mathematics. 1983

Awards

Excellence in Research Award. 2006

Andrew W. Mellon Dean's Teaching Scholar. 1997 - 2000

Phi Beta Kappa. 1983

Publications

Journal Articles

Patient-reported disease burden in the Accelerate Clinical Trials in Charcot-Marie-Tooth Disease Study.

Rehbein T, Purks J, Dilek N, Behrens-Spraggins S, Sowden JE, Eichinger KJ, , Burns J, Pareyson D, Scherer SS, Reilly MM, Shy ME, McDermott MP, Heatwole CR, Herrmann DN

Journal of the peripheral nervous system : JPNS.. 2024 October 10 Epub 10/10/2024.

Personalized Outcomes in Neuropathic Pain: A Clinical Relevance and Assay Sensitivity Analysis from a Randomized Controlled Trial.

Saab K, Gada U, Culakova E, Burnette B, Jorgensen C, Shah D, Morrow G, Mustian K, Sohn MB, Edwards RR, Freeman R, Langford DJ, McDermott MP, Gewandter JS

Pain medicine : the official journal of the American Academy of Pain Medicine.. 2024 October 4 Epub 10/04/2024.

Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial.

Vivekanandam V, Skorupinska I, Jayaseelan DL, Matthews E, Barohn RJ, McDermott MP, Hanna MG

The Lancet. Neurology.. 2024 October 23 (10):1004-1012. Epub 1900 01 01.

Acetaminophen and Ibuprofen in Pediatric Central Nervous System Malaria: A Randomized Clinical Trial.

Birbeck GL, Seydel KB, Mwanza S, Tembo D, Chilombe M, Watts A, Ume-Ezeoke I, Mathews M, Patel AA, Mwenechanya M, Pensulo P, McDermott MP

JAMA neurology.. 2024 August 181 (8):857-865. Epub 1900 01 01.

The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.

Benatar M, Wuu J, Huey ED, McMillan CT, Petersen RC, Postuma R, McHutchison C, Dratch L, Arias JJ, Crawley A, Houlden H, McDermott MP, Cai X, Thakur N, Boxer A, Rosen H, Boeve BF, Dacks P, Cosentino S, Abrahams S, Shneider N, Lingor P, Shefner J, Andersen PM, Al-Chalabi A, Turner MR

Nature reviews. Neurology.. 2024 June 20 (6):364-376. Epub 05/20/2024.

Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.

Benatar M, Wuu J, Huey ED, McMillan CT, Petersen RC, Postuma R, McHutchison C, Dratch L, Arias JJ, Crawley A, Houlden H, McDermott MP, Cai X, Thakur N, Boxer A, Rosen H, Boeve BF, Dacks P, Cosentino S, Abrahams S, Shneider N, Lingor P, Shefner J, Andersen PM, Al-Chalabi A, Turner MR,

Nature reviews. Neurology.. 2024 June 20 (6):377. Epub 1900 01 01.

Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial.

Schiava M, McDermott MP, Broomfield J, Abrams KR, Mayhew AG, McDonald CM, Martens WB, Gregory SJ, Griggs RC, Guglieri M,

Neurology.. 2024 May 28102 (10):e209206. Epub 05/06/2024.

Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes.

Nishtar M, Mark R, Langford DJ, McDermott MP, Markman JD, Evans SR, France FO, Park M, Sharma S, Turk DC, Dworkin RH, Gewandter JS

Regional anesthesia and pain medicine.. 2024 May 749 (5):363-367. Epub 05/07/2024.

Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement.

Hohenschurz-Schmidt D, Cherkin D, Rice ASC, Dworkin RH, Turk DC, McDermott MP, Bair MJ, DeBar LL, Edwards RR, Evans SR, Farrar JT, Kerns RD, Rowbotham MC, Wasan AD, Cowan P, Ferguson M, Freeman R, Gewandter JS, Gilron I, Grol-Prokopczyk H, Iyengar S, Kamp C, Karp BI, Kleykamp BA, Loeser JD, Mackey S, Malamut R, McNicol E, Patel KV, Schmader K, Simon L, Steiner DJ, Veasley C, Vollert J

Pain.. 2024 May 3 Epub 05/03/2024.

Reference curves of motor function outcomes in young steroid-naïve males with Duchenne muscular dystrophy.

Hoskens J, Schiava M, Goemans N, Feys H, McDermott MP, Martens WB, Mayhew A, Griggs RC, Klingels K, Guglieri M

Developmental medicine and child neurology.. 2024 May 66 (5):644-653. Epub 10/26/2023.

Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint Hypermobility.

Harding ER, Kanner CH, Pasternak A, Glanzman AM, Dunaway Young S, Rao AK, McDermott MP, Zolkipli-Cunningham Z, Day JW, Finkel RS, Darras BT, De Vivo DC, Montes J

Journal of clinical medicine.. 2024 April 3013 (9)Epub 04/30/2024.

Reply to "Capturing Synergy Holistically in Psychedelic Clinical Trials".

Dworkin RH, McDermott MP, Nayak SM, Strain EC

Clinical pharmacology and therapeutics.. 2024 March 115 (3):401-402. Epub 01/02/2024.

A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).

Varma A, Todinca MS, Eichinger K, Heininger S, Dilek N, Martens W, Tawil R, Statland J, Kissel JT, McDermott MP, Heatwole C

Muscle & nerve.. 2024 March 69 (3):362-367. Epub 01/08/2024.

Protocol for a magnetic resonance imaging study of participants in the fever RCT: Does fever control prevent brain injury in malaria?

Chilombe MB, Seydel KB, Hammond CA, Mwanza S, Patel AA, Lungu F, Wa Somwe S, Kampondeni S, Potchen MJ, McDermott MP, Birbeck GL

PloS one.. 2024 19 (4):e0294823. Epub 04/19/2024.

Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?

Dworkin RH, McDermott MP, Nayak SM, Strain EC

Clinical pharmacology and therapeutics.. 2023 December 114 (6):1166-1169. Epub 10/05/2023.

Association between neurodevelopmental impairments and motor function in Duchenne muscular dystrophy.

Thangarajh M, McDermott MP, Guglieri M, Griggs RC

Annals of clinical and translational neurology.. 2023 December 10 (12):2285-2296. Epub 10/07/2023.

The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.

Varma A, Weinstein J, Seabury J, Rosero S, Engebrecht C, Wagner E, Zizzi C, Luebbe EA, Dilek N, McDermott MP, Kissel J, Sansone V, Heatwole C

Muscle & nerve.. 2023 October 68 (4):422-431. Epub 08/23/2023.

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.

Machado PM, McDermott MP, Blaettler T, Sundgreen C, Amato AA, Ciafaloni E, Freimer M, Gibson SB, Jones SM, Levine TD, Lloyd TE, Mozaffar T, Shaibani AI, Wicklund M, Rosholm A, Carstensen TD, Bonefeld K, Jørgensen AN, Phonekeo K, Heim AJ, Herbelin L, Barohn RJ, Hanna MG, Dimachkie MM,

The Lancet. Neurology.. 2023 October 22 (10):900-911. Epub 1900 01 01.

What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update.

Langford DJ, Baron R, Edwards RR, Gewandter JS, Gilron I, Griffin R, Kamerman PR, Katz NP, McDermott MP, Rice ASC, Turk DC, Vollert J, Dworkin RH

Pain.. 2023 September 1164 (9):1927-1930. Epub 06/07/2023.

Covariate Adjustment in Chronic Pain Trials: An Oft-Missed Opportunity.

Langford DJ, Sharma S, McDermott MP, Beeram A, Besherat S, France FO, Mark R, Park M, Nishtar M, Turk DC, Dworkin RH, Gewandter JS

The journal of pain.. 2023 September 24 (9):1555-1569. Epub 06/14/2023.

Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy.

Wang LH, Leung DG, Wagner KR, Lowry SJ, McDermott MP, Eichinger K, Higgs K, Walker M, Lewis L, Martens WB, Mul K, Sansone VA, Shieh P, Elsheikh B, LoRusso S, Butterfield RJ, Johnson N, Preston MR, Messina C, Carraro E, Tawil R, Statland J,

Neuromuscular disorders : NMD.. 2023 September 33 (9):63-68. Epub 06/21/2023.

Teacher Knowledge of Tourette Syndrome and Associated Factors.

Sapozhnikov Y, Mink JW, Augustine EF, Adams HR, Vierhile A, Lewin AB, Collins AT, McDermott MP, O'Connor T, Kurlan R, Murphy TK, Vermilion J

Pediatric neurology.. 2023 August 145 :80-87. Epub 05/16/2023.

A systematic review of the potential consequences of abnormal serum levels of vitamin B6 in people living with Parkinson's disease.

Modica JS, Déry C, Canissario R, Logigian E, Bonno D, Stanton M, Dupré N, McDermott MP, Bouchard M, Lang AE, Lizarraga KJ

Journal of the neurological sciences.. 2023 July 15450 :120690. Epub 05/18/2023.

Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement.

Hohenschurz-Schmidt DJ, Cherkin D, Rice ASC, Dworkin RH, Turk DC, McDermott MP, Bair MJ, DeBar LL, Edwards RR, Farrar JT, Kerns RD, Markman JD, Rowbotham MC, Sherman KJ, Wasan AD, Cowan P, Desjardins P, Ferguson M, Freeman R, Gewandter JS, Gilron I, Grol-Prokopczyk H, Hertz SH, Iyengar S, Kamp C, Karp BI, Kleykamp BA, Loeser JD, Mackey S, Malamut R, McNicol E, Patel KV, Sandbrink F, Schmader K, Simon L, Steiner DJ, Veasley C, Vollert J

Pain.. 2023 July 1164 (7):1457-1472. Epub 03/22/2023.

Perceived exertion is not a substitute for fatiguability in spinal muscular atrophy.

Cheng R, Feng J, Goodwin AM, Uher D, Rao AK, McDermott MP, De Vivo DC, Ewing Garber C, Montes J

Muscle & nerve.. 2023 July 68 (1):81-84. Epub 12/26/2022.

The Lessebo Effect in Disease Modification Trials in Parkinson's Disease.

Mestre TA, McDermott MP, Lobo R, Ferreira JJ, Lang AE

Movement disorders : official journal of the Movement Disorder Society.. 2023 July 38 (7):1346-1350. Epub 04/24/2023.

Expectations for Improvement: A Neglected but Potentially Important Covariate or Moderator for Chronic Pain Clinical Trials.

Langford DJ, Lou R, Sheen S, Amtmann D, Colloca L, Edwards RR, Farrar JT, Katz NP, McDermott MP, Reeve BB, Wasan AD, Turk DC, Dworkin RH, Gewandter JS

The journal of pain.. 2023 April 24 (4):575-581. Epub 12/26/2022.

Real-world data and evidence in pain research: a qualitative systematic review of methods in current practice.

Vollert J, Kleykamp BA, Farrar JT, Gilron I, Hohenschurz-Schmidt D, Kerns RD, Mackey S, Markman JD, McDermott MP, Rice ASC, Turk DC, Wasan AD, Dworkin RH

Pain reports.. 2023 8 (2):e1057. Epub 02/01/2023.

Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported Outcomes.

Young SD, Pasternak A, Duong T, McGrattan KE, Stranberg S, Maczek E, Dias C, Tang W, Parker D, Levine A, Rohan A, Wolford C, Martens W, McDermott MP, Darras BT, Day JW

Journal of neuromuscular diseases.. 2023 10 (2):199-209. Epub 1900 01 01.

Does unconscious socioeconomic bias influence tele-evaluation of obstructive sleep apnea? An exploratory analysis.

Yurcheshen ME, Pigeon W, Marcus CZ, Marcus JA, McDermott MP, Consagra W, Nguyen K, Marsella J

Sleep medicine.. 2022 December 100 :225-229. Epub 08/11/2022.

Milestones of progression in myotonic dystrophy type 1 and type 2.

Hamel JI, McDermott MP, Hilbert JE, Martens WB, Luebbe E, Tawil R, Moxley RT, Thornton CA

Muscle & nerve.. 2022 October 66 (4):508-512. Epub 07/21/2022.

A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results.

Jensen-Roberts S, Myers TL, Auinger P, Cannon P, Rowbotham HM, Coker D, Chanoff E, Soto J, Pawlik M, Amodeo K, Sharma S, Valdovinos B, Wilson R, Sarkar A, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Holloway RG, Dorsey ER, Schneider RB

Neurology. Genetics.. 2022 October 8 (5):e200008. Epub 08/11/2022.

Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations.

Kleykamp BA, Dworkin RH, Turk DC, Bhagwagar Z, Cowan P, Eccleston C, Ellenberg SS, Evans SR, Gewandter JS, Goli V, Farrar JT, Freeman RL, Garrison LP, Iyengar S, Jadad AR, Jensen MP, Junor R, Katz NP, Kesslak JP, Kopecky EA, Lissin D, Markman JD, McDermott MP, Mease PJ, O'Connor AB, Patel KV, Raja SN, Rowbotham MC, Sampaio C, Singh JA, Steigerwald I, Strand V, Tive LA, Tobias J, Wasan AD, Wilson HD

Pain.. 2022 June 1163 (6):1006-1018. Epub 09/09/2021.

Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy.

Mayhew AG, Moat D, McDermott MP, Eagle M, Griggs RC, King WM, James MK, Muni-Lofra R, Shillington A, Gregson S, Pallant L, Skura C, Staudt LA, Eichinger K, McMurchie H, Rabb R, Di Marco M, Brown S, Zanin R, Arnoldi MT, McIntyre M, Wilson A, Alfano LN, Lowes LP, Blomgren C, Milev E, Iodice M, Pasternak A, Chiu A, Lehnert I, Claus N, Dieruf KA, Rolle E, Nicorici A, Andres B, Hobbiebrunken E, Roetmann G, Kern V, Civitello M, Vogt S, Hayes MJ, Scholtes C, Lacroix C, Gunn T, Warner S, Newman J, Barp A, Kundrat K, Kovelman S, Powers PJ, Guglieri M,

Neuromuscular disorders : NMD.. 2022 June 32 (6):460-467. Epub 02/26/2022.

Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.

Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Speed C, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Griggs RC, , Straub V, van Ruiten H, Childs AM, Ciafaloni E, Shieh PB, Spinty S, Maggi L, Baranello G, Butterfield RJ, Horrocks IA, Roper H, Alhaswani Z, Flanigan KM, Kuntz NL, Manzur A, Darras BT, Kang PB, Morrison L, Krzesniak-Swinarska M, Mah JK, Mongini TE, Ricci F, von der Hagen M, Finkel RS, O'Reardon K, Wicklund M, Kumar A, McDonald CM, Han JJ, Joyce N, Henricson EK, Schara-Schmidt U, Gangfuss A, Wilichowski E, Barohn RJ, Statland JM, Campbell C, Vita G, Vita GL, Howard JF, Hughes I, McMillan HJ, Pegoraro E, Bello L, Burnette WB, Thangarajh M, Chang T

JAMA.. 2022 April 19327 (15):1456-1468. Epub 1900 01 01.

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.

Benatar M, Wuu J, McHutchison C, Postuma RB, Boeve BF, Petersen R, Ross CA, Rosen H, Arias JJ, Fradette S, McDermott MP, Shefner J, Stanislaw C, Abrahams S, Cosentino S, Andersen PM, Finkel RS, Granit V, Grignon AL, Rohrer JD, McMillan CT, Grossman M, Al-Chalabi A, Turner MR,

Brain : a journal of neurology.. 2022 March 29145 (1):27-44. Epub 1900 01 01.

Clinical and Genetic Characteristics in Young, Glucocorticoid-Naive Boys With Duchenne Muscular Dystrophy.

Schiava M, Amos R, VanRuiten H, McDermott MP, Martens WB, Gregory S, Mayhew A, McColl E, Tawil R, Willis T, Bushby K, Griggs RC, Guglieri M,

Neurology.. 2022 January 2498 (4):e390-e401. Epub 01/24/2022.

Adaptive dose-response studies to establish proof-of-concept in learning-phase clinical trials.

Ma S, McDermott MP

Biometrical journal. Biometrische Zeitschrift.. 2022 January 64 (1):146-164. Epub 10/04/2021.

Risk Behaviors in Youth With and Without Tourette Syndrome.

Vermilion J, Augustine EF, Adams HR, Vierhile A, Collins AT, McDermott MP, O'Connor TG, Kurlan R, van Wijngaarden E, Mink JW

Pediatric neurology.. 2022 January 126 :20-25. Epub 10/19/2021.

The Huntington's Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure.

Brumfield OS, Zizzi CE, Dilek N, Alexandrou DG, Glidden AM, Rosero S, Weinstein J, Seabury J, Kaat A, McDermott MP, Dorsey ER, Heatwole CR

Journal of Huntington's disease.. 2022 11 (2):217-226. Epub 1900 01 01.

Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A.

Eichinger K, Sowden JE, Burns J, McDermott MP, Krischer J, Thornton J, Pareyson D, Scherer SS, Shy ME, Reilly MM, Herrmann DN

Frontiers in neurology. 2022 13 :930435. Epub 06/27/2022.

Aggressive antipyretics in central nervous system malaria: Study protocol of a randomized-controlled trial assessing antipyretic efficacy and parasite clearance effects (Malaria FEVER study).

Chilombe MB, McDermott MP, Seydel KB, Mathews M, Mwenechanya M, Birbeck GL

PloS one.. 2022 17 (10):e0268414. Epub 10/07/2022.

Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy.

Campbell C, McColl E, McDermott MP, Martens WB, Guglieri M, Griggs RC,

Neuromuscular disorders : NMD.. 2021 November 31 (11):1161-1168. Epub 06/10/2021.

Composite outcomes for pain clinical trials: considerations for design and interpretation.

Gewandter JS, McDermott MP, Evans S, Katz NP, Markman JD, Simon LS, Turk DC, Dworkin RH

Pain.. 2021 July 1162 (7):1899-1905. Epub 1900 01 01.

The Spinal Muscular Atrophy Health Index: A novel outcome for measuring how a patient feels and functions.

Zizzi CE, Luebbe E, Mongiovi P, Hunter M, Dilek N, Garland C, Ciafaloni E, Zaidman CM, Kissel JT, McDermott MP, Johnson N, Sansone V, Heatwole CR

Muscle & nerve.. 2021 June 63 (6):837-844. Epub 03/24/2021.

Nusinersen Treatment in Adults With Spinal Muscular Atrophy.

Duong T, Wolford C, McDermott MP, Macpherson CE, Pasternak A, Glanzman AM, Martens WB, Kichula E, Darras BT, De Vivo DC, Zolkipli-Cunningham Z, Finkel RS, Zeineh M, Wintermark M, Sampson J, Hagerman KA, Young SD, Day JW

Neurology. Clinical practice.. 2021 June 11 (3):e317-e327. Epub 1900 01 01.

Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy.

Montes J, Goodwin AM, McDermott MP, Uher D, Hernandez FM, Coutts K, Cocchi J, Hauschildt M, Cornett KM, Rao AK, Monani UR, Ewing Garber C, De Vivo DC

Annals of clinical and translational neurology.. 2021 May 8 (5):1086-1095. Epub 03/31/2021.

Anxiety Symptoms Differ in Youth With and Without Tic Disorders.

Vermilion J, Pedraza C, Augustine EF, Adams HR, Vierhile A, Lewin AB, Collins AT, McDermott MP, O'Connor T, Kurlan R, van Wijngaarden E, Murphy TK, Mink JW

Child psychiatry and human development.. 2021 April 52 (2):301-310. Epub 1900 01 01.

Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.

Heatwole C, Luebbe E, Rosero S, Eichinger K, Martens W, Hilbert J, Dekdebrun J, Dilek N, Zizzi C, Johnson N, Puwanant A, Tawil R, Schifitto G, Beck CA, Richeson JF, Zareba W, Thornton C, McDermott MP, Moxley R

Neurology.. 2021 January 1296 (2):e228-e240. Epub 10/12/2020.

Essential statistical principles of clinical trials of pain treatments.

Dworkin RH, Evans SR, Mbowe O, McDermott MP

Pain reports.. 2021 6 (1):e863. Epub 12/18/2020.

The ACTTION Guide to Clinical Trials of Pain Treatments, part II: mitigating bias, maximizing value.

Dworkin RH, Kerns RD, McDermott MP, Turk DC, Veasley C

Pain reports.. 2021 6 (1):e886. Epub 01/21/2021.

Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.

Mestre TA, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, van Hilten AJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Marinus J, Mollenhauer B, Postuma R, Rajalingam R, Rodríguez-Violante M, Simuni T, James Surmeier D, Weintraub D, McDermott MP, Lawton M, Marras C

Journal of Parkinson's disease.. 2021 11 (2):395-404. Epub 1900 01 01.

Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.

Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, Markman JD, Oaklander AL, Polydefkis MJ, Raja SN, Robinson JP, Woolf CJ, Ziegler D, Ashburn MA, Burke LB, Cowan P, George SZ, Goli V, Graff OX, Iyengar S, Jay GW, Katz J, Kehlet H, Kitt RA, Kopecky EA, Malamut R, McDermott MP, Palmer P, Rappaport BA, Rauschkolb C, Steigerwald I, Tobias J, Walco GA

Pain reports.. 2021 6 (1):e895. Epub 01/21/2021.

Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy.

Fragala-Pinkham M, Pasternak A, McDermott MP, Mirek E, Glanzman AM, Montes J, Dunaway Young S, Salazar R, Quigley J, Riley SO, Chiriboga CA, Finkel RS, Tennekoon G, Martens WB, De Vivo DC, Darras BT

Journal of pediatric rehabilitation medicine.. 2021 14 (3):451-461. Epub 1900 01 01.

Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.

Smith SM, Dworkin RH, Turk DC, McDermott M, Eccleston C, Farrar JT, Rowbotham MC, Bhangwagar Z, Burke LB, Cowan P, Ellenberg SS, Evans SR, Freeman RL, Garrison LP, Iyengar S, Jadad A, Jensen MP, Junor R, Kamp C, Katz NP, Kesslak JP, Kopecky EA, Lissin D, Markman JD, Mease PJ, O'Connor AB, Patel KV, Raja SN, Sampaio C, Schoenfeld D, Singh J, Steigerwald I, Strand V, Tive LA, Tobias J, Wasan AD, Wilson HD

Pain.. 2020 November 161 (11):2446-2461. Epub 1900 01 01.

Estimands and missing data in clinical trials of chronic pain treatments: advances in design and analysis.

Cai X, Gewandter JS, He H, Turk DC, Dworkin RH, McDermott MP

Pain.. 2020 October 161 (10):2308-2320. Epub 1900 01 01.

Incremental Gains in the Battle against ALS.

Benatar M, McDermott MP

The New England journal of medicine.. 2020 September 3383 (10):979-980. Epub 1900 01 01.

John D. Loeser Award Lecture: Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials.

Smith SM, Fava M, Jensen MP, Mbowe OB, McDermott MP, Turk DC, Dworkin RH

Pain.. 2020 September 161 Suppl 1 (1):S3-S13. Epub 1900 01 01.

Huntington's Disease and Hypertension: Sorting Out Mixed Messages.

Marras C, Mestre T, McDermott MP

Movement disorders : official journal of the Movement Disorder Society.. 2020 June 35 (6):915-917. Epub 1900 01 01.

When should non-significant results influence clinical decisions?: Interpreting confidence intervals.

Gewandter JS, McDermott MP

BJOG : an international journal of obstetrics and gynaecology.. 2020 April 127 (5):548-549. Epub 01/07/2020.

Tic Disorders are Associated With Lower Child and Parent Quality of Life and Worse Family Functioning.

Vermilion J, Augustine E, Adams HR, Vierhile A, Lewin AB, Thatcher A, McDermott MP, O'Connor T, Kurlan R, van Wijngaarden E, Murphy TK, Mink JW

Pediatric neurology.. 2020 April 105 :48-54. Epub 12/27/2019.

Generalized multiple contrast tests in dose-response studies.

Ma S, McDermott MP

Statistics in medicine.. 2020 March 1539 (6):757-772. Epub 12/02/2019.

Are there really only 2 kinds of people in the world? Evaluating the distribution of change from baseline in pain clinical trials.

Mbowe OB, Gewandter JS, Turk DC, Dworkin RH, McDermott MP

Pain.. 2020 January 161 (1):195-201. Epub 1900 01 01.

Ankle bracing practices in ambulatory, corticosteroid-naive boys with Duchenne muscular dystrophy.

Kern V, Wicklund M, Haulman A, McDermott MP, Martens WB, Griggs RC, Kumar A,

Muscle & nerve.. 2020 January 61 (1):52-57. Epub 10/16/2019.

Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.

Gewandter JS, Dworkin RH, Turk DC, Devine EG, Hewitt D, Jensen MP, Katz NP, Kirkwood AA, Malamut R, Markman JD, Vrijens B, Burke L, Campbell JN, Carr DB, Conaghan PG, Cowan P, Doyle MK, Edwards RR, Evans SR, Farrar JT, Freeman R, Gilron I, Juge D, Kerns RD, Kopecky EA, McDermott MP, Niebler G, Patel KV, Rauck R, Rice ASC, Rowbotham M, Sessler NE, Simon LS, Singla N, Skljarevski V, Tockarshewsky T, Vanhove GF, Wasan AD, Witter J

The journal of pain.. 2020 21 (9-10):931-942. Epub 12/13/2019.

Baseline Variables Associated with Functional Decline in 2CARE, A Randomized Clinical Trial in Huntington's Disease.

McGarry A, McDermott MP, Kieburtz K, Peng J, Cudkowicz M,

Journal of Huntington's disease.. 2020 9 (1):47-58. Epub 1900 01 01.

Deep Phenotyping of Parkinson's Disease.

Dorsey ER, Omberg L, Waddell E, Adams JL, Adams R, Ali MR, Amodeo K, Arky A, Augustine EF, Dinesh K, Hoque ME, Glidden AM, Jensen-Roberts S, Kabelac Z, Katabi D, Kieburtz K, Kinel DR, Little MA, Lizarraga KJ, Myers T, Riggare S, Rosero SZ, Saria S, Schifitto G, Schneider RB, Sharma G, Shoulson I, Stevenson EA, Tarolli CG, Luo J, McDermott MP

Journal of Parkinson's disease.. 2020 10 (3):855-873. Epub 1900 01 01.

A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.

Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, , Holloway RG, Dorsey ER

Journal of Parkinson's disease.. 2020 10 (3):1195-1207. Epub 1900 01 01.

Relationships between mutations and neurodevelopment in dystrophinopathy.

Thangarajh M, Hendriksen J, McDermott MP, Martens W, Hart KA, Griggs RC,

Neurology.. 2019 October 2293 (17):e1597-e1604. Epub 10/08/2019.

WITHDRAWN: Size Does Matter, But It Isn't Everything: The Challenge of Modest Treatment Effects in Chronic Pain Clinical Trials.

Smith SM, Fava M, Jensen MP, Mbowe OB, McDermott MP, Turk DC, Dworkin RH

The journal of pain.. 2019 September 30 Epub 09/30/2019.

Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).

Hamel J, Johnson N, Tawil R, Martens WB, Dilek N, McDermott MP, Heatwole C

Neurology.. 2019 September 1793 (12):e1180-e1192. Epub 08/13/2019.

Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.

LoRusso S, Johnson NE, McDermott MP, Eichinger K, Butterfield RJ, Carraro E, Higgs K, Lewis L, Mul K, Sacconi S, Sansone VA, Shieh P, van Engelen B, Wagner K, Wang L, Statland JM, Tawil R,

BMC neurology.. 2019 September 1019 (1):224. Epub 09/10/2019.

Demonstrating Heterogeneity of Treatment Effects Among Patients: An Overlooked but Important Step Toward Precision Medicine.

Gewandter JS, McDermott MP, He H, Gao S, Cai X, Farrar JT, Katz NP, Markman JD, Senn S, Turk DC, Dworkin RH

Clinical pharmacology and therapeutics.. 2019 July 106 (1):204-210. Epub 03/12/2019.

Navigating trials of personalized pain treatments: we're going to need a bigger boat.

Gewandter JS, McDermott MP, Mbowe O, Edwards RR, Katz NP, Turk DC, Dworkin RH

Pain.. 2019 June 160 (6):1235-1239. Epub 1900 01 01.

Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

McGarry A, McDermott MP, Kieburtz K, Alan Fung WL, McCusker E, Peng J, de Blieck EA, Cudkowicz M,

Neurology.. 2019 April 292 (14):e1643-e1651. Epub 03/08/2019.

Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved Outcomes.

Schneider RB, Lu X, Biglan K, McDermott MP

Movement disorders clinical practice.. 2019 March 6 (3):222-226. Epub 01/28/2019.

Neurodevelopmental Impairments 1 Year After Cerebral Malaria.

Langfitt JT, McDermott MP, Brim R, Mboma S, Potchen MJ, Kampondeni SD, Seydel KB, Semrud-Clikeman M, Taylor TE

Pediatrics.. 2019 February 143 (2)Epub 01/29/2019.

Ethical considerations in the design, execution, and analysis of clinical trials of chronic pain treatments.

Rowbotham MC, McDermott MP

Pain reports.. 2019 4 (3):e646. Epub 03/29/2018.

The ACTTION Guide to Clinical Trials of Pain Treatments: standing on the shoulders of giants.

Dworkin RH, Kerns RD, McDermott MP, Turk DC, Veasley C

Pain reports.. 2019 4 (3):e757. Epub 06/07/2019.

Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA).

Mongiovi P, Dilek N, Garland C, Hunter M, Kissel JT, Luebbe E, McDermott MP, Johnson N, Heatwole C

Neurology.. 2018 September 2591 (13):e1206-e1214. Epub 08/24/2018.

A Comparison of the Assay Sensitivity of Average and Worst Pain Intensity in Pharmacologic Trials: An ACTTION Systematic Review and Meta-Analysis.

Smith SM, Jensen MP, He H, Kitt R, Koch J, Pan A, Burke LB, Farrar JT, McDermott MP, Turk DC, Dworkin RH

The journal of pain.. 2018 September 19 (9):953-960. Epub 03/26/2018.

Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations.

Gewandter JS, Brell J, Cavaletti G, Dougherty PM, Evans S, Howie L, McDermott MP, O'Mara A, Smith AG, Dastros-Pitei D, Gauthier LR, Haroutounian S, Jarpe M, Katz NP, Loprinzi C, Richardson P, Lavoie-Smith EM, Wen PY, Turk DC, Dworkin RH, Freeman R

Neurology.. 2018 August 2891 (9):403-413. Epub 07/27/2018.

The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome.

Johnson NE, Heatwole C, Creigh P, McDermott MP, Dilek N, Hung M, Bounsanga J, Tang W, Shy ME, Herrmann DN

Annals of neurology.. 2018 August 84 (2):225-233. Epub 08/29/2018.

Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function.

Salazar R, Montes J, Dunaway Young S, McDermott MP, Martens W, Pasternak A, Quigley J, Mirek E, Glanzman AM, Civitello M, Gee R, Duong T, Mazzone ES, Main M, Mayhew A, Ramsey D, Muni Lofra R, Coratti G, Fanelli L, De Sanctis R, Forcina N, Chiriboga C, Darras BT, Tennekoon GI, Scoto M, Day JW, Finkel R, Muntoni F, Mercuri E, De Vivo DC

Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association.. 2018 July 30 (3):209-215. Epub 1900 01 01.

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.

Crow RA, Hart KA, McDermott MP, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Hirtz D, Lochmuller H, Straub V, Ciafaloni E, Shieh PB, Spinty S, Childs AM, Manzur AY, Morandi L, Butterfield RJ, Horrocks I, Roper H, Flanigan KM, Kuntz NL, Mah JK, Morrison L, Darras BT, von der Hagen M, Schara U, Wilichowski E, Mongini T, McDonald CM, Vita G, Barohn RJ, Finkel RS, Wicklund M, McMillan HJ, Hughes I, Pegoraro E, Bryan Burnette W, Howard JF, Thangarajh M, Campbell C, Griggs RC, Bushby K, Guglieri M

Trials.. 2018 May 1019 (1):291. Epub 05/10/2018.

Myotonic dystrophy patient preferences in patient-reported outcome measures.

Heatwole C, Johnson N, Dekdebrun J, Dilek N, Eichinger K, Hilbert J, Luebbe E, Martens W, McDermott MP, Thornton C, Moxley R

Muscle & nerve.. 2018 January 12 Epub 01/12/2018.

Ambulatory function in spinal muscular atrophy: Age-related patterns of progression.

Montes J, McDermott MP, Mirek E, Mazzone ES, Main M, Glanzman AM, Duong T, Young SD, Salazar R, Pasternak A, Gee R, De Sanctis R, Coratti G, Forcina N, Fanelli L, Ramsey D, Milev E, Civitello M, Pane M, Pera MC, Scoto M, Day JW, Tennekoon G, Finkel RS, Darras BT, Muntoni F, De Vivo DC, Mercuri E

PloS one.. 2018 13 (6):e0199657. Epub 06/26/2018.

High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.

Hilbert JE, Barohn RJ, Clemens PR, Luebbe EA, Martens WB, McDermott MP, Parkhill AL, Tawil R, Thornton CA, Moxley RT,

Neurology.. 2017 September 2689 (13):1348-1354. Epub 08/30/2017.

Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations.

Gewandter JS, Freeman R, Kitt RA, Cavaletti G, Gauthier LR, McDermott MP, Mohile NA, Mohlie SG, Smith AG, Tejani MA, Turk DC, Dworkin RH

Neurology.. 2017 August 2289 (8):859-869. Epub 07/26/2017.

Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendations.

Gewandter JS, McDermott MP, Kitt RA, Chaudari J, Koch JG, Evans SR, Gross RA, Markman JD, Turk DC, Dworkin RH

BMJ open.. 2017 July 187 (7):e017288. Epub 07/18/2017.

In-vivo reflectance confocal microscopy of Meissner's corpuscles in diabetic distal symmetric polyneuropathy.

Creigh PD, McDermott MP, Sowden JE, Ferguson M, Herrmann DN

Journal of the neurological sciences.. 2017 July 15378 :213-219. Epub 05/12/2017.

The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Smith SM, Dworkin RH, Turk DC, Baron R, Polydefkis M, Tracey I, Borsook D, Edwards RR, Harris RE, Wager TD, Arendt-Nielsen L, Burke LB, Carr DB, Chappell A, Farrar JT, Freeman R, Gilron I, Goli V, Haeussler J, Jensen T, Katz NP, Kent J, Kopecky EA, Lee DA, Maixner W, Markman JD, McArthur JC, McDermott MP, Parvathenani L, Raja SN, Rappaport BA, Rice AS, Rowbotham MC, Tobias JK, Wasan AD, Witter J

The journal of pain.. 2017 July 18 (7):757-777. Epub 02/27/2017.

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.

Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Hirtz D, Shieh PB, Straub V, Childs AM, Ciafaloni E, Butterfield RJ, Horrocks I, Spinty S, Flanigan KM, Kuntz NL, Baranello G, Roper H, Morrison L, Mah JK, Manzur AY, McDonald CM, Schara U, von der Hagen M, Barohn RJ, Campbell C, Darras BT, Finkel RS, Vita G, Hughes I, Mongini T, Pegoraro E, Wicklund M, Wilichowski E, Bryan Burnette W, Howard JF, McMillan HJ, Thangarajh M, Griggs RC

Contemporary clinical trials.. 2017 July 58 :34-39. Epub 04/24/2017.

A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned.

Parkinsonism & related disorders.. 2017 April 37 :101-105. Epub 02/14/2017.

Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy.

Gewandter JS, Burke L, Cavaletti G, Dworkin RH, Gibbons C, Gover TD, Herrmann DN, McArthur Mb JC, McDermott MP, Rappaport BA, Reeve BB, Russell JW, Smith AG, Smith SM, Turk DC, Vinik AI, Freeman R

Muscle & nerve.. 2017 March 55 (3):366-372. Epub 12/23/2016.

Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic review.

Gewandter JS, Kitt RA, Hunsinger MR, Poku J, Lozano J, Chaudari J, Evans S, Gross RA, McDermott MP, Rowbotham MC, Turk DC, Dworkin RH

Journal of clinical epidemiology.. 2017 March 83 :101-107. Epub 01/23/2017.

Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.

Libien J, Kupersmith MJ, Blaner W, McDermott MP, Gao S, Liu Y, Corbett J, Wall M,

Journal of the neurological sciences.. 2017 January 15372 :78-84. Epub 11/10/2016.

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M,

Neurology.. 2017 January 1088 (2):152-159. Epub 12/02/2016.

Reporting of Design Features and Analysis Details in Randomized Clinical Trials of Procedural Treatments for Cancer Pain: An ACTTION Systematic Review.

Rothstein D, Kitt RA, Smith SM, Abdi S, Engle MP, McDermott MP, Raja SN, Turk DC, Dworkin RH, Gewandter JS

Regional anesthesia and pain medicine.. 2017 42 (3):392-399. Epub 1900 01 01.

Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.

Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N

Journal of Huntington's disease.. 2017 6 (2):149-156. Epub 1900 01 01.

Mentoring Interventions for Underrepresented Scholars in Biomedical and Behavioral Sciences: Effects on Quality of Mentoring Interactions and Discussions.

Lewis V, Martina CA, McDermott MP, Chaudron L, Trief PM, LaGuardia JG, Sharp D, Goodman SR, Morse GD, Ryan RM

CBE life sciences education.. 2017 16 (3)Epub 1900 01 01.

Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.

Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N

Journal of Huntington's disease.. 2017 6 (4):371. Epub 1900 01 01.

Rasch analysis of the Pediatric Evaluation of Disability Inventory-computer adaptive test (PEDI-CAT) item bank for children and young adults with spinal muscular atrophy.

Pasternak A, Sideridis G, Fragala-Pinkham M, Glanzman AM, Montes J, Dunaway S, Salazar R, Quigley J, Pandya S, O'Riley S, Greenwood J, Chiriboga C, Finkel R, Tennekoon G, Martens WB, McDermott MP, Szelag Fournier H, Madabusi L, Harrington T, Cruz RE, LaMarca NM, Videon NM, De Vivo DC, Darras BT, ,

Muscle & nerve.. 2016 December 54 (6):1097-1107. Epub 10/06/2016.

Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial.

Bruce BB, Digre KB, McDermott MP, Schron EB, Wall M,

Neurology.. 2016 November 187 (18):1871-1877. Epub 09/30/2016.

Reporting of cross-over clinical trials of analgesic treatments for chronic pain: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks systematic review and recommendations.

Gewandter JS, McDermott MP, McKeown A, Hoang K, Iwan K, Kralovic S, Rothstein D, Gilron I, Katz NP, Raja SN, Senn S, Smith SM, Turk DC, Dworkin RH

Pain.. 2016 November 157 (11):2544-2551. Epub 1900 01 01.

Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review.

Williams MR, McKeown A, Pressman Z, Hunsinger M, Lee K, Coplan P, Gilron I, Katz NP, McDermott MP, Raja SN, Rappaport BA, Rowbotham MC, Turk DC, Dworkin RH, Smith SM

The journal of pain.. 2016 November 17 (11):1137-1149. Epub 08/12/2016.

Meta-analysis with missing study-level sample variance data.

Chowdhry AK, Dworkin RH, McDermott MP

Statistics in medicine.. 2016 July 3035 (17):3021-32. Epub 02/16/2016.

A Randomized Controlled Trial of Mentoring Interventions for Underrepresented Minorities.

Lewis V, Martina CA, McDermott MP, Trief PM, Goodman SR, Morse GD, LaGuardia JG, Sharp D, Ryan RM

Academic medicine : journal of the Association of American Medical Colleges.. 2016 July 91 (7):994-1001. Epub 1900 01 01.

A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension.

Weil R, Kovacs B, Miller N, McDermott MP, Wall M, Kupersmith M, Pi-Sunyer FX,

Obesity science & practice.. 2016 June 2 (2):95-103. Epub 04/05/2016.

Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system.

Smith SM, Amtmann D, Askew RL, Gewandter JS, Hunsinger M, Jensen MP, McDermott MP, Patel KV, Williams M, Bacci ED, Burke LB, Chambers CT, Cooper SA, Cowan P, Desjardins P, Etropolski M, Farrar JT, Gilron I, Huang IZ, Katz M, Kerns RD, Kopecky EA, Rappaport BA, Resnick M, Strand V, Vanhove GF, Veasley C, Versavel M, Wasan AD, Turk DC, Dworkin RH

Pain.. 2016 May 157 (5):1056-1064. Epub 1900 01 01.

Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.

Sansone VA, Burge J, McDermott MP, Smith PC, Herr B, Tawil R, Pandya S, Kissel J, Ciafaloni E, Shieh P, Ralph JW, Amato A, Cannon SC, Trivedi J, Barohn R, Crum B, Mitsumoto H, Pestronk A, Meola G, Conwit R, Hanna MG, Griggs RC,

Neurology.. 2016 April 1286 (15):1408-1416. Epub 02/10/2016.

Deficiencies in reporting of statistical methodology in recent randomized trials of nonpharmacologic pain treatments: ACTTION systematic review.

Dworkin JD, McKeown A, Farrar JT, Gilron I, Hunsinger M, Kerns RD, McDermott MP, Rappaport BA, Turk DC, Dworkin RH, Gewandter JS

Journal of clinical epidemiology.. 2016 April 72 :56-65. Epub 11/18/2015.

Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations.

Andrews NA, Latrémolière A, Basbaum AI, Mogil JS, Porreca F, Rice AS, Woolf CJ, Currie GL, Dworkin RH, Eisenach JC, Evans S, Gewandter JS, Gover TD, Handwerker H, Huang W, Iyengar S, Jensen MP, Kennedy JD, Lee N, Levine J, Lidster K, Machin I, McDermott MP, McMahon SB, Price TJ, Ross SE, Scherrer G, Seal RP, Sena ES, Silva E, Stone L, Svensson CI, Turk DC, Whiteside G

Pain.. 2016 April 157 (4):901-909. Epub 1900 01 01.

Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.

Benatar M, Mcdermott MP, Sanders DB, Wolfe GI, Barohn RJ, Nowak RJ, Hehir M, Juel V, Katzberg H, Tawil R,

Muscle & nerve.. 2016 March 53 (3):363-9. Epub 01/27/2016.

Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.

ten Hove MW, Friedman DI, Patel AD, Irrcher I, Wall M, McDermott MP,

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.. 2016 March 36 (1):13-9. Epub 1900 01 01.

Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL,

Investigative ophthalmology & visual science.. 2016 March 57 (3):805-12. Epub 1900 01 01.

Myotonic dystrophy health index: Correlations with clinical tests and patient function.

Heatwole C, Bode R, Nicholas Johnson , Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, McDermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT

Muscle & nerve.. 2016 February 53 (2):183-90. Epub 12/29/2015.

Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations.

Cooper SA, Desjardins PJ, Turk DC, Dworkin RH, Katz NP, Kehlet H, Ballantyne JC, Burke LB, Carragee E, Cowan P, Croll S, Dionne RA, Farrar JT, Gilron I, Gordon DB, Iyengar S, Jay GW, Kalso EA, Kerns RD, McDermott MP, Raja SN, Rappaport BA, Rauschkolb C, Royal MA, Segerdahl M, Stauffer JW, Todd KH, Vanhove GF, Wallace MS, West C, White RE, Wu C

Pain.. 2016 February 157 (2):288-301. Epub 1900 01 01.

A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension

Weil, R; Kovacs B; Miller N; McDermott MP; Wall M; Kupersmith M; Pi-Sunyer X; the NORDIC Idiopathic Intracranial Hypertension Study Group.

Obesity Science and Practice. 2016; 2: 95-103.

Age at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet.

Ciafaloni E, Kumar A, Liu K, Pandya S, Westfield C, Fox DJ, Caspers Conway KM, Cunniff C, Mathews K, West N, Romitti PA, McDermott MP

Journal of pediatric rehabilitation medicine.. 2016 9 (1):5-11. Epub 1900 01 01.

Physical therapy services received by individuals with spinal muscular atrophy (SMA).

Dunaway S, Montes J, McDermott MP, Martens W, Neisen A, Glanzman AM, Pasternak A, Riley S, Sproule D, Chiriboga C, Finkel R, Tennekoon G, Darras B, De Vivo D, Pandya S

Journal of pediatric rehabilitation medicine.. 2016 9 (1):35-44. Epub 1900 01 01.

Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).

Heatwole C, Johnson N, Bode R, Dekdebrun J, Dilek N, Hilbert JE, Luebbe E, Martens W, McDermott MP, Quinn C, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT

Neurology.. 2015 December 1585 (24):2136-46. Epub 11/18/2015.

Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.

Montes J, Glanzman AM, Mazzone ES, Martens WB, Dunaway S, Pasternak A, Riley SO, Quigley J, Pandya S, De Vivo DC, Kaufmann P, Chiriboga CA, Finkel RS, Tennekoon GI, Darras BT, Pane M, Mercuri E, Mcdermott MP,

Muscle & nerve.. 2015 December 52 (6):942-7. Epub 10/10/2015.

CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.

Kattah JC, Pula JH, Mejico LJ, McDermott MP, Kupersmith MJ, Wall M

Journal of neurology.. 2015 October 262 (10):2271-4. Epub 07/10/2015.

Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.

Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP,

Neurology.. 2015 September 185 (9):799-805. Epub 08/05/2015.

Assay sensitivity of pain intensity versus pain relief in acute pain clinical trials: ACTTION systematic review and meta-analysis.

Singla N, Hunsinger M, Chang PD, McDermott MP, Chowdhry AK, Desjardins PJ, Turk DC, Dworkin RH

The journal of pain.. 2015 August 16 (8):683-91. Epub 04/16/2015.

Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.

Johnson NE, Arnold WD, Hebert D, Gwathmey K, Dimachkie MM, Barohn RJ, McVey AL, Pasnoor M, Amato AA, McDermott MP, Kissel J, Heatwole CR

Neuromuscular disorders : NMD.. 2015 August 25 (8):625-31. Epub 05/07/2015.

Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.

Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, Markman JD, Oaklander AL, Polydefkis MJ, Raja SN, Robinson JP, Woolf CJ, Ziegler D, Ashburn MA, Burke LB, Cowan P, George SZ, Goli V, Graff OX, Iyengar S, Jay GW, Katz J, Kehlet H, Kitt RA, Kopecky EA, Malamut R, McDermott MP, Palmer P, Rappaport BA, Rauschkolb C, Steigerwald I, Tobias J, Walco GA

Pain.. 2015 July 156 (7):1184-1197. Epub 1900 01 01.

Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results.

Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M,

Neurology.. 2015 June 1684 (24):2449-56. Epub 05/20/2015.

A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis.

Markman JD, Gewandter JS, Frazer ME, Murray NM, Rast SA, McDermott MP, Chowdhry AK, Tompkinson E, Pilcher WH, Walter KA, Dworkin RH

Spine.. 2015 May 1540 (10):684-91. Epub 1900 01 01.

Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.

Fischer WS, Wall M, McDermott MP, Kupersmith MJ, Feldon SE,

Investigative ophthalmology & visual science.. 2015 May 56 (5):3292-303. Epub 1900 01 01.

Prospective study of muscle cramps in Charcot-Marie-tooth disease.

Johnson NE, Sowden J, Dilek N, Eichinger K, Burns J, McDermott MP, Shy ME, Herrmann DN

Muscle & nerve.. 2015 April 51 (4):485-8. Epub 02/11/2015.

Quality of pain intensity assessment reporting: ACTTION systematic review and recommendations.

Smith SM, Hunsinger M, McKeown A, Parkhurst M, Allen R, Kopko S, Lu Y, Wilson HD, Burke LB, Desjardins P, McDermott MP, Rappaport BA, Turk DC, Dworkin RH

The journal of pain.. 2015 April 16 (4):299-305. Epub 01/28/2015.

Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review.

McKeown A, Gewandter JS, McDermott MP, Pawlowski JR, Poli JJ, Rothstein D, Farrar JT, Gilron I, Katz NP, Lin AH, Rappaport BA, Rowbotham MC, Turk DC, Dworkin RH, Smith SM

The journal of pain.. 2015 March 16 (3):199-206.e1-7. Epub 12/04/2014.

Neurocognitive Changes after Sustained Ketamine Administration in Children with Chronic Pain.

Bredlau AL, Harel BT, McDermott MP, Dworkin RH, Korones DN, Dolan JG, Adams HR

Journal of palliative care & medicine. 2015 March 5 (2)Epub 03/27/2015.

Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication.

Markman JD, Frazer ME, Rast SA, McDermott MP, Gewandter JS, Chowdhry AK, Czerniecka K, Pilcher WH, Simon LS, Dworkin RH

Neurology.. 2015 January 2084 (3):265-72. Epub 12/10/2014.

Data interpretation in analgesic clinical trials with statistically nonsignificant primary analyses: an ACTTION systematic review.

Gewandter JS, McKeown A, McDermott MP, Dworkin JD, Smith SM, Gross RA, Hunsinger M, Lin AH, Rappaport BA, Rice AS, Rowbotham MC, Williams MR, Turk DC, Dworkin RH

The journal of pain.. 2015 January 16 (1):3-10. Epub 10/23/2014.

Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis pain.

Dworkin RH, Turk DC, Peirce-Sandner S, He H, McDermott MP, Hochberg MC, Jordan JM, Katz NP, Lin AH, Neogi T, Rappaport BA, Simon LS, Strand V

Arthritis & rheumatology.. 2014 December 66 (12):3327-36. Epub 1900 01 01.

Reporting of intention-to-treat analyses in recent analgesic clinical trials: ACTTION systematic review and recommendations.

Gewandter JS, McDermott MP, McKeown A, Smith SM, Pawlowski JR, Poli JJ, Rothstein D, Williams MR, Bujanover S, Farrar JT, Gilron I, Katz NP, Rowbotham MC, Turk DC, Dworkin RH

Pain.. 2014 December 155 (12):2714-2719. Epub 10/02/2014.

Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review.

Hunsinger M, Smith SM, Rothstein D, McKeown A, Parkhurst M, Hertz S, Katz NP, Lin AH, McDermott MP, Rappaport BA, Turk DC, Dworkin RH

Pain.. 2014 November 155 (11):2253-62. Epub 08/12/2014.

Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations.

Gewandter JS, Dworkin RH, Turk DC, McDermott MP, Baron R, Gastonguay MR, Gilron I, Katz NP, Mehta C, Raja SN, Senn S, Taylor C, Cowan P, Desjardins P, Dimitrova R, Dionne R, Farrar JT, Hewitt DJ, Iyengar S, Jay GW, Kalso E, Kerns RD, Leff R, Leong M, Petersen KL, Ravina BM, Rauschkolb C, Rice AS, Rowbotham MC, Sampaio C, Sindrup SH, Stauffer JW, Steigerwald I, Stewart J, Tobias J, Treede RD, Wallace M, White RE

Pain.. 2014 September 155 (9):1683-1695. Epub 05/24/2014.

Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations.

Gewandter JS, McDermott MP, McKeown A, Smith SM, Williams MR, Hunsinger M, Farrar J, Turk DC, Dworkin RH

Pain.. 2014 September 155 (9):1871-1877. Epub 06/30/2014.

Observational study of spinal muscular atrophy type I and implications for clinical trials.

Finkel RS, McDermott MP, Kaufmann P, Darras BT, Chung WK, Sproule DM, Kang PB, Foley AR, Yang ML, Martens WB, Oskoui M, Glanzman AM, Flickinger J, Montes J, Dunaway S, O'Hagen J, Quigley J, Riley S, Benton M, Ryan PA, Montgomery M, Marra J, Gooch C, De Vivo DC

Neurology.. 2014 August 2683 (9):810-7. Epub 07/30/2014.

Cognition and mood in perimenopause: a systematic review and meta-analysis.

Weber MT, Maki PM, McDermott MP

The Journal of steroid biochemistry and molecular biology.. 2014 July 142 :90-8. Epub 06/14/2013.

Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure.

Heatwole C, Bode R, Johnson N, Dekdebrun J, Dilek N, Heatwole M, Hilbert JE, Luebbe E, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley R

Muscle & nerve.. 2014 June 49 (6):906-14. Epub 1900 01 01.

Disclosure of authorship contributions in analgesic clinical trials and related publications: ACTTION systematic review and recommendations.

Hunsinger M, Smith SM, McKeown A, Parkhurst M, Gross RA, Lin AH, McDermott MP, Rappaport BA, Turk DC, Dworkin RH

Pain.. 2014 June 155 (6):1059-1063. Epub 12/12/2013.

The idiopathic intracranial hypertension treatment trial: design considerations and methods.

Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ, Wall M,

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.. 2014 June 34 (2):107-17. Epub 1900 01 01.

The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP,

JAMA neurology.. 2014 June 71 (6):693-701. Epub 1900 01 01.

The motor neuron response to SMN1 deficiency in spinal muscular atrophy.

Kang PB, Gooch CL, McDermott MP, Darras BT, Finkel RS, Yang ML, Sproule DM, Chung WK, Kaufmann P, de Vivo DC,

Muscle & nerve.. 2014 May 49 (5):636-44. Epub 1900 01 01.

Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment.

Dworkin RH, McDermott MP, Farrar JT, O'Connor AB, Senn S

Pain.. 2014 March 155 (3):457-460. Epub 09/23/2013.

Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations.

Gewandter JS, Smith SM, McKeown A, Burke LB, Hertz SH, Hunsinger M, Katz NP, Lin AH, McDermott MP, Rappaport BA, Williams MR, Turk DC, Dworkin RH

Pain.. 2014 March 155 (3):461-466. Epub 11/23/2013.

Designing clinical trials for dystonia.

Galpern WR, Coffey CS, Albanese A, Cheung K, Comella CL, Ecklund DJ, Fahn S, Jankovic J, Kieburtz K, Lang AE, McDermott MP, Shefner JM, Teller JK, Thompson JL, Yeatts SD, Jinnah HA

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.. 2014 January 11 (1):117-27. Epub 1900 01 01.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ

JAMA.. 2014 311 (16):1641-51. Epub 1900 01 01.

Splicing biomarkers of disease severity in myotonic dystrophy.

Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, Dekdebrun J, Heatwole CR, McDermott MP, Chen T, Cline M, Tawil R, Osborne RJ, Wheeler TM, Swanson M, Moxley RT, Thornton CA

Annals of neurology.. 2013 December 74 (6):862-72. Epub 1900 01 01.

Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations.

Smith SM, Wang AT, Pereira A, Daniel Chang R, McKeown A, Greene K, Rowbotham MC, Burke LB, Coplan P, Gilron I, Hertz SH, Katz NP, Lin AH, McDermott MP, Papadopoulos EJ, Rappaport BA, Sweeney M, Turk DC, Dworkin RH

Pain.. 2013 December 154 (12):2769-2774. Epub 08/17/2013.

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease.

Zhang J, Mattison HA, Liu C, Ginghina C, Auinger P, McDermott MP, Stewart T, Kang UJ, , Cain KC, Shi M

Acta neuropathologica.. 2013 November 126 (5):671-82. Epub 05/04/2013.

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.

O'Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O'Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin RW, Haddox JD, Hertz S, Jay GW, Junor R, Kopecky EA, Leiderman DB, McDermott MP, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP

Pain.. 2013 November 154 (11):2324-2334. Epub 1900 01 01.

Diagnostic odyssey of patients with myotonic dystrophy.

Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP, Tawil R, Thornton CA, Moxley RT

Journal of neurology.. 2013 October 260 (10):2497-504. Epub 06/27/2013.

A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease.

Movement disorders : official journal of the Movement Disorder Society.. 2013 September 28 (10):1407-15. Epub 02/28/2013.

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial.

Schapira AH, McDermott MP, Barone P, Comella CL, Albrecht S, Hsu HH, Massey DH, Mizuno Y, Poewe W, Rascol O, Marek K

The Lancet. Neurology.. 2013 August 12 (8):747-55. Epub 05/31/2013.

High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.

Lewis RA, McDermott MP, Herrmann DN, Hoke A, Clawson LL, Siskind C, Feely SM, Miller LJ, Barohn RJ, Smith P, Luebbe E, Wu X, Shy ME,

JAMA neurology.. 2013 August 70 (8):981-7. Epub 1900 01 01.

Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysis.

Dworkin RH, Turk DC, Peirce-Sandner S, He H, McDermott MP, Farrar JT, Katz NP, Lin AH, Rappaport BA, Rowbotham MC

Neurology.. 2013 July 281 (1):67-75. Epub 05/22/2013.

Oral ketamine for children with chronic pain: a pilot phase 1 study.

Bredlau AL, McDermott MP, Adam HR, Dworkin RH, Venuto C, Fisher SG, Dolan JG, Korones DN

The Journal of pediatrics.. 2013 July 163 (1):194-200.e1. Epub 02/10/2013.

Corticosteroids in Duchenne muscular dystrophy: major variations in practice.

Griggs RC, Herr BE, Reha A, Elfring G, Atkinson L, Cwik V, McColl E, Tawil R, Pandya S, McDermott MP, Bushby K

Muscle & nerve.. 2013 July 48 (1):27-31. Epub 04/25/2013.

Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations.

Smith SM, Wang AT, Katz NP, McDermott MP, Burke LB, Coplan P, Gilron I, Hertz SH, Lin AH, Rappaport BA, Rowbotham MC, Sampaio C, Sweeney M, Turk DC, Dworkin RH

Pain.. 2013 July 154 (7):997-1008. Epub 03/14/2013.

Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.

Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R

Neuromuscular disorders : NMD.. 2013 April 23 (4):306-12. Epub 02/11/2013.

Caffeine consumption and risk of dyskinesia in CALM-PD.

Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA,

Movement disorders : official journal of the Movement Disorder Society.. 2013 March 28 (3):380-3. Epub 01/21/2013.

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.

JAMA neurology.. 2013 January 70 (1):25-33. Epub 1900 01 01.

Estimation and inference concerning ordered means in analysis of covariance models with interactions

Morrissette JL; McDermott MP.

Journal of the American Statistical Association. 2013; 108: 832-839.

SMA-MAP: a plasma protein panel for spinal muscular atrophy.

Kobayashi DT, Shi J, Stephen L, Ballard KL, Dewey R, Mapes J, Chung B, McCarthy K, Swoboda KJ, Crawford TO, Li R, Plasterer T, Joyce C, , Chung WK, Kaufmann P, Darras BT, Finkel RS, Sproule DM, Martens WB, McDermott MP, De Vivo DC, , Walker MG, Chen KS

PloS one.. 2013 8 (4):e60113. Epub 04/02/2013.

Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic review.

Smith SM, Chang RD, Pereira A, Shah N, Gilron I, Katz NP, Lin AH, McDermott MP, Rappaport BA, Rowbotham MC, Sampaio C, Turk DC, Dworkin RH

Pain.. 2012 December 153 (12):2415-2421. Epub 09/15/2012.

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations.

Comer SD, Zacny JP, Dworkin RH, Turk DC, Bigelow GE, Foltin RW, Jasinski DR, Sellers EM, Adams EH, Balster R, Burke LB, Cerny I, Colucci RD, Cone E, Cowan P, Farrar JT, Haddox JD, Haythornthwaite JA, Hertz S, Jay GW, Johanson CE, Junor R, Katz NP, Klein M, Kopecky EA, Leiderman DB, McDermott MP, O'Brien C, O'Connor AB, Palmer PP, Raja SN, Rappaport BA, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Sokolowska M, Stauffer JW, Walsh SL

Pain.. 2012 December 153 (12):2315-2324. Epub 09/19/2012.

HIV neuropathy: an in vivo confocal microscopic study.

Almodovar JL, Schifitto G, McDermott MP, Ferguson M, Herrmann DN

Journal of neurovirology.. 2012 December 18 (6):503-10. Epub 10/16/2012.

Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.

Benatar M, Sanders DB, Wolfe GI, McDermott MP, Tawil R

Annals of the New York Academy of Sciences.. 2012 December 1275 :17-22. Epub 1900 01 01.

Prospective cohort study of spinal muscular atrophy types 2 and 3.

Kaufmann P, McDermott MP, Darras BT, Finkel RS, Sproule DM, Kang PB, Oskoui M, Constantinescu A, Gooch CL, Foley AR, Yang ML, Tawil R, Chung WK, Martens WB, Montes J, Battista V, O'Hagen J, Dunaway S, Flickinger J, Quigley J, Riley S, Glanzman AM, Benton M, Ryan PA, Punyanitya M, Montgomery MJ, Marra J, Koo B, De Vivo DC, ,

Neurology.. 2012 October 3079 (18):1889-97. Epub 10/17/2012.

Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).

Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R

Neurology.. 2012 July 2479 (4):348-57. Epub 07/11/2012.

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowan P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R, Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice AS, Sampaio C, Skljarevski V, Sommerville K, Stacey BR, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Williams J, Witter J, Ziegler D

Pain.. 2012 June 153 (6):1148-1158. Epub 04/09/2012.

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, Panisset M, Christine CW, Jiang W, Singer C, Horn S, Pfeiffer R, Rottenberg D, Slevin J, Elmer L, Press D, Hyson HC, McDonald W,

Neurology.. 2012 April 1778 (16):1229-36. Epub 04/11/2012.

Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.

Engel J, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, Sperling MR, Gardiner I, Erba G, Fried I, Jacobs M, Vinters HV, Mintzer S, Kieburtz K,

JAMA.. 2012 March 7307 (9):922-30. Epub 1900 01 01.

If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).

Hilbert JE, Kissel JT, Luebbe EA, Martens WB, McDermott MP, Sanders DB, Tawil R, Thornton CA, Moxley RT,

Contemporary clinical trials.. 2012 March 33 (2):302-11. Epub 11/26/2011.

Urine phenobarbital drug screening: potential use for compliance assessment in neonates.

Guillet R, Kwon JM, Chen S, McDermott MP

Journal of child neurology.. 2012 February 27 (2):200-3. Epub 09/27/2011.

Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis.

Lowes LP, Alfano L, Viollet L, Rosales XQ, Sahenk Z, Kaspar BK, Clark KR, Flanigan KM, Mendell JR, McDermott MP

Muscle & nerve.. 2012 February 45 (2):163-8. Epub 1900 01 01.

A robust method using propensity score stratification for correcting verification bias for binary tests.

He H, McDermott MP

Biostatistics.. 2012 January 13 (1):32-47. Epub 08/18/2011.

A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease.

Parkinsonism & related disorders.. 2011 December 17 (10):757-60. Epub 08/06/2011.

Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III.

Glanzman AM, O'Hagen JM, McDermott MP, Martens WB, Flickinger J, Riley S, Quigley J, Montes J, Dunaway S, Deng L, Chung WK, Tawil R, Darras BT, De Vivo DC, Kaufmann P, Finkel RS, ,

Journal of child neurology.. 2011 December 26 (12):1499-507. Epub 09/21/2011.

A randomized, pilot trial of etanercept in dermatomyositis.

Annals of neurology.. 2011 September 70 (3):427-36. Epub 06/17/2011.

In vivo confocal microscopy of Meissner corpuscles as a novel sensory measure in CMT1A.

Almodovar JL, Ferguson M, McDermott MP, Lewis RA, Shy ME, Herrmann DN

Journal of the peripheral nervous system : JPNS.. 2011 September 16 (3):169-74. Epub 1900 01 01.

Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.

Murphy SM, Herrmann DN, McDermott MP, Scherer SS, Shy ME, Reilly MM, Pareyson D

Journal of the peripheral nervous system : JPNS.. 2011 September 16 (3):191-8. Epub 1900 01 01.

Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.

Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, Constantinescu A, Sproule DM, Foley AR, Yang M, Tawil R, Chung W, Martens B, Montes J, O'Hagen J, Dunaway S, Flickinger JM, Quigley J, Riley S, Glanzman AM, Benton M, Ryan PA, Irvine C, Annis CL, Butler H, Caracciolo J, Montgomery M, Marra J, Koo B, De Vivo DC, ,

Archives of neurology.. 2011 June 68 (6):779-86. Epub 02/14/2011.

Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT database.

Dworkin RH, Peirce-Sandner S, Turk DC, McDermott MP, Gibofsky A, Simon LS, Farrar JT, Katz NP

Osteoarthritis and cartilage. 2011 May 19 (5):483-92. Epub 03/23/2011.

Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION.

Dworkin RH, Turk DC, Katz NP, Rowbotham MC, Peirce-Sandner S, Cerny I, Clingman CS, Eloff BC, Farrar JT, Kamp C, McDermott MP, Rappaport BA, Sanhai WR

Pain.. 2011 March 152 (3 Suppl):S107-S115. Epub 12/09/2010.

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.

Marras C, McDermott MP, Marek K, Rochon P, Naglie G, Tanner CM, Rudolph A, Shoulson I, Lang AE,

Movement disorders : official journal of the Movement Disorder Society.. 2011 March 26 (4):608-13. Epub 02/01/2011.

High prevalence of hypovitaminosis D status in patients with early Parkinson disease.

Evatt ML, DeLong MR, Kumari M, Auinger P, McDermott MP, Tangpricha V,

Archives of neurology.. 2011 March 68 (3):314-9. Epub 1900 01 01.

Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.

Heatwole CR, Eichinger KJ, Friedman DI, Hilbert JE, Jackson CE, Logigian EL, Martens WB, McDermott MP, Pandya SK, Quinn C, Smirnow AM, Thornton CA, Moxley RT

Archives of neurology.. 2011 January 68 (1):37-44. Epub 09/13/2010.

Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.

Kieburtz K,

Movement disorders : official journal of the Movement Disorder Society.. 2011 January 26 (1):37-44. Epub 10/05/2010.

Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND).

Glanzman AM, McDermott MP, Montes J, Martens WB, Flickinger J, Riley S, Quigley J, Dunaway S, O'Hagen J, Deng L, Chung WK, Tawil R, Darras BT, Yang M, Sproule D, De Vivo DC, Kaufmann P, Finkel RS, ,

Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association.. 2011 23 (4):322-6. Epub 1900 01 01.

The authorship lottery: an impediment to research collaboration?

Kaufmann P, Annis C, Griggs RC,

Annals of neurology.. 2010 December 68 (6):782-6. Epub 1900 01 01.

A futility study of minocycline in Huntington's disease.

Movement disorders : official journal of the Movement Disorder Society.. 2010 October 1525 (13):2219-24. Epub 1900 01 01.

Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsy.

Engel J, McDermott MP, Wiebe S, Langfitt JT, Erba G, Gardiner I, Stern J, Dewar S, Sperling MR, Jacobs M, Kieburtz K,

Epilepsia.. 2010 October 51 (10):1978-86. Epub 1900 01 01.

Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females.

Stratigopoulos G, Lanzano P, Deng L, Guo J, Kaufmann P, Darras B, Finkel R, Tawil R, McDermott MP, Martens W, Devivo DC, Chung WK

Archives of neurology.. 2010 October 67 (10):1252-6. Epub 1900 01 01.

Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.

, Hyson HC, Kieburtz K, Shoulson I, McDermott M, Ravina B, de Blieck EA, Cudkowicz ME, Ferrante RJ, Como P, Frank S, Zimmerman C, Cudkowicz ME, Ferrante K, Newhall K, Jennings D, Kelsey T, Walker F, Hunt V, Daigneault S, Goldstein M, Weber J, Watts A, Beal MF, Browne SE, Metakis LJ

Movement disorders : official journal of the Movement Disorder Society.. 2010 September 1525 (12):1924-8. Epub 1900 01 01.

Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study.

Schapira AH, Albrecht S, Barone P, Comella CL, McDermott MP, Mizuno Y, Poewe W, Rascol O, Marek K

Movement disorders : official journal of the Movement Disorder Society.. 2010 August 1525 (11):1627-32. Epub 1900 01 01.

Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database.

Dworkin RH, Turk DC, Peirce-Sandner S, McDermott MP, Farrar JT, Hertz S, Katz NP, Raja SN, Rappaport BA

Pain.. 2010 July 150 (1):12-16. Epub 03/03/2010.

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Logigian EL, Martens WB, Moxley RT, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT

Neurology.. 2010 May 474 (18):1441-8. Epub 1900 01 01.

Toward more efficient clinical trials for amyotrophic lateral sclerosis.

Cudkowicz ME, Katz J, Moore DH, O'Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott MP, Miller RG

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.. 2010 May 311 (3):259-65. Epub 1900 01 01.

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S, Jadad AR, Jay GW, Kalliomäki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath PJ, Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Reeve BB, Rhodes T, Sampaio C, Simpson DM, Stauffer JW, Stucki G, Tobias J, White RE, Witter J

Pain.. 2010 May 149 (2):177-193. Epub 03/06/2010.

Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy.

Montes J, McDermott MP, Martens WB, Dunaway S, Glanzman AM, Riley S, Quigley J, Montgomery MJ, Sproule D, Tawil R, Chung WK, Darras BT, De Vivo DC, Kaufmann P, Finkel RS,

Neurology.. 2010 March 974 (10):833-8. Epub 1900 01 01.

Sex differences in outcome after mild traumatic brain injury.

Bazarian JJ, Blyth B, Mookerjee S, He H, McDermott M

Journal of neurotrauma.. 2010 March 27 (3):527-39. Epub 1900 01 01.

A randomized trial of memantine as treatment for spasticity in multiple sclerosis.

Mehta LR, McDermott MP, Goodman AD, Schwid SR

Multiple sclerosis : clinical and laboratory research.. 2010 February 16 (2):248-51. Epub 12/22/2009.

A randomized controlled trial of telephone peer support's influence on breastfeeding duration in adolescent mothers.

Meglio GD, McDermott MP, Klein JD

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.. 2010 February 5 (1):41-7. Epub 1900 01 01.

A randomized, placebo-controlled trial of latrepirdine in Huntington disease.

Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, Seely L, Walker F, Feigin A, ,

Archives of neurology.. 2010 February 67 (2):154-60. Epub 1900 01 01.

The relationship between uric acid levels and Huntington's disease progression.

Auinger P, Kieburtz K, McDermott MP

Movement disorders : official journal of the Movement Disorder Society.. 2010 January 3025 (2):224-8. Epub 1900 01 01.

Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, Rauschkolb C, Sampaio C

Pain.. 2009 December 146 (3):238-244. Epub 1900 01 01.

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC,

Neurology.. 2009 November 373 (18):1469-77. Epub 1900 01 01.

Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model.

Yurcheshen ME, Guttuso T, McDermott M, Holloway RG, Perlis M

Journal of women's health.. 2009 September 18 (9):1355-60. Epub 1900 01 01.

Is a history of gestational diabetes related to risk factors for coronary heart disease?

King KB, Gerich JE, Guzick DS, King KU, McDermott MP

Research in nursing & health.. 2009 June 32 (3):298-306. Epub 1900 01 01.

Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.

Archives of neurology.. 2009 May 66 (5):563-70. Epub 1900 01 01.

A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.

Dworkin RH, Barbano RL, Tyring SK, Betts RF, McDermott MP, Pennella-Vaughan J, Bennett GJ, Berber E, Gnann JW, Irvine C, Kamp C, Kieburtz K, Max MB, Schmader KE

Pain.. 2009 April 142 (3):209-217. Epub 02/04/2009.

Direct estimation of the area under the receiver operating characteristic curve in the presence of verification bias.

He H, Lyness JM, McDermott MP

Statistics in medicine.. 2009 February 128 (3):361-76. Epub 1900 01 01.

Effect of L-methionine on hot flashes in postmenopausal women: a randomized controlled trial.

Guttuso T, McDermott MP, Ng P, Kieburtz K

Menopause : the journal of the North American Menopause Society.. 2009 16 (5):1004-8. Epub 1900 01 01.

Adjunctive chemotherapeutic suppression of mutans streptococci in the setting of severe early childhood caries: an exploratory study.

Berkowitz RJ, Koo H, McDermott MP, Whelehan MT, Ragusa P, Kopycka-Kedzierawski DT, Karp JM, Billings R

Journal of public health dentistry.. 2009 69 (3):163-7. Epub 1900 01 01.

Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis.

Wolfe GI, Barohn RJ, Sanders DB, McDermott MP,

Muscle & nerve.. 2008 November 38 (5):1429-1433. Epub 1900 01 01.

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.

Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J

Pain.. 2008 October 31139 (3):485-493. Epub 08/15/2008.

Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection.

Hall CB, Caserta MT, Schnabel K, Shelley LM, Marino AS, Carnahan JA, Yoo C, Lofthus GK, McDermott MP

Pediatrics.. 2008 September 122 (3):513-20. Epub 1900 01 01.

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.

Neurology.. 2008 August 571 (6):394-9. Epub 04/23/2008.

The relationship between CAG repeat length and clinical progression in Huntington's disease.

Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP

Movement disorders : official journal of the Movement Disorder Society.. 2008 July 1523 (9):1223-7. Epub 1900 01 01.

Effects of L-isoleucine and L-valine on hot flushes and serum homocysteine: a randomized controlled trial.

Guttuso T, McDermott MP, Su H, Kieburtz K

Obstetrics and gynecology.. 2008 July 112 (1):109-15. Epub 1900 01 01.

Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study.

Kurlan R, Johnson D, Kaplan EL,

Pediatrics.. 2008 June 121 (6):1188-97. Epub 1900 01 01.

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE,

Movement disorders : official journal of the Movement Disorder Society.. 2008 April 1523 (5):653-9; quiz 776. Epub 1900 01 01.

Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.

Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, , Leurgans S

Movement disorders : official journal of the Movement Disorder Society.. 2008 April 1523 (5):690-9. Epub 1900 01 01.

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S

The journal of pain.. 2008 February 9 (2):105-21. Epub 12/11/2007.

Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.

Palumbo DR, Sallee FR, Pelham WE, Bukstein OG, Daviss WB, McDermott MP

Journal of the American Academy of Child and Adolescent Psychiatry.. 2008 February 47 (2):180-188. Epub 1900 01 01.

Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.

Daviss WB, Patel NC, Robb AS, McDermott MP, Bukstein OG, Pelham WE, Palumbo D, Harris P, Sallee FR

Journal of the American Academy of Child and Adolescent Psychiatry.. 2008 February 47 (2):189-198. Epub 1900 01 01.

Neuropathy progression in Charcot-Marie-Tooth disease type 1A.

Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP

Neurology.. 2008 January 2970 (5):378-83. Epub 1900 01 01.

Developmental changes in soluble CD40 ligand.

Cholette JM, Blumberg N, Phipps RP, McDermott MP, Gettings KF, Lerner NB

The Journal of pediatrics.. 2008 January 152 (1):50-4, 54.e1. Epub 10/24/2007.

Testing equality of means under order restrictions using multiple contrasts.

Kost JT; McDermott MP.

Commun Statist Theory Methods. 2008; 37(19): 3029-3039.

Clinical trials of drugs used off-label in neonates: ethical issues and alternative study designs.

Amin SB, McDermott MP, Shamoo AE

Accountability in research.. 2008 15 (3):168-87. Epub 1900 01 01.

A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone).

Constantinescu R, McDermott MP, Dicenzo R, de Blieck EA, Hyson HC, Beal MF, Bednarczyk EM, Bogdanov M, Metakis LJ, Browne SE, Lorenzo BJ, Ravina B, Kieburtz K

Journal of clinical pharmacology.. 2007 December 47 (12):1580-6. Epub 10/09/2007.

Human herpesvirus (HHV)-6 and HHV-7 infections in pregnant women.

Caserta MT, Hall CB, Schnabel K, Lofthus G, McDermott MP

The Journal of infectious diseases.. 2007 November 1196 (9):1296-303. Epub 10/01/2007.

Infectivity of herpes simplex virus type-1 (HSV-1) amplicon vectors in dendritic cells is determined by the helper virus strain used for packaging.

Santos K, Sanfilippo CM, Narrow WC, Casey AE, Rodriguez-Colon SM, McDermott MP, Federoff HJ, Bowers WJ, Dewhurst S

Journal of virological methods.. 2007 October 145 (1):37-46. Epub 07/02/2007.

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients.

Flickinger J, O'Hagen JM, Quigley J, Glanzman AM, Riley S, McDermott MP, Sanborn E, Ryan PA, Irvine C, Flickinger J, Martens WB, Quigley J, Annis C, Riley S, Tawil R, Sanborn E, Oskoui M, Irvine C, Darras BT, Martens WB, Finkel RS, Annis C, De Vivo DC, Tawil R, Oskoui M, Darras BT, Finkel RS, De Vivo DC

Neuromuscular disorders : NMD.. 2007 October 17 (9-10):693-7. Epub 07/19/2007.

Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery.

Cholette JM, Rubenstein JS, Alfieris GM, McDermott MP, Harmon WG, Vermilion R, Eaton MP, Gangemi JJ, Lerner NB

The Annals of thoracic surgery.. 2007 October 84 (4):1320-5. Epub 1900 01 01.

Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia.

Wachtman LM, Skolasky RL, Tarwater PM, Esposito D, Schifitto G, Marder K, McDermott MP, Cohen BA, Nath A, Sacktor N, Epstein LG, Mankowski JL, McArthur JC

Archives of neurology.. 2007 September 64 (9):1264-72. Epub 1900 01 01.

GDNF in Parkinson's disease: the perils of post-hoc power.

Matcham J, McDermott MP, Lang AE

Journal of neuroscience methods.. 2007 July 30163 (2):193-6. Epub 05/07/2007.

Impact of pramipexole on the onset of levodopa-related dyskinesias.

Constantinescu R, Romer M, McDermott MP, Kamp C, Kieburtz K,

Movement disorders : official journal of the Movement Disorder Society.. 2007 July 1522 (9):1317-9. Epub 1900 01 01.

Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.

Biglan KM, Holloway RG, McDermott MP, Richard IH,

Neurology.. 2007 July 1069 (2):187-95. Epub 1900 01 01.

Health care costs decline after successful epilepsy surgery.

Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S

Neurology.. 2007 April 1768 (16):1290-8. Epub 1900 01 01.

Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial.

Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP,

Journal of the neurological sciences.. 2007 April 15255 (1-2):57-63. Epub 02/28/2007.

An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.

Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, Conant K, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Marder K, Epstein LG

Archives of neurology.. 2007 January 64 (1):97-102. Epub 1900 01 01.

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.

Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M, Scott J, Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar JT, Haythornthwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath P, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von Stein T, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW,

Pain.. 2006 December 5125 (3):208-215. Epub 10/25/2006.

Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.

Hauser RA, McDermott MP, Messing S

Archives of neurology.. 2006 December 63 (12):1756-60. Epub 1900 01 01.

A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams.

Butler-O'Hara M, Buzzard CJ, Reubens L, McDermott MP, DiGrazio W, D'Angio CT

Pediatrics.. 2006 July 118 (1):e25-35. Epub 06/19/2006.

Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy.

Langfitt JT, Vickrey BG, McDermott MP, Messing S, Berg AT, Spencer SS, Sperling MR, Bazil CW, Shinnar S

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation.. 2006 June 15 (5):899-914. Epub 1900 01 01.

Characteristics and acquisition of human herpesvirus (HHV) 7 infections in relation to infection with HHV-6.

Hall CB, Caserta MT, Schnabel KC, McDermott MP, Lofthus GK, Carnahan JA, Gilbert LM, Dewhurst S

The Journal of infectious diseases.. 2006 April 15193 (8):1063-9. Epub 03/06/2006.

Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study.

Herrmann DN, McDermott MP, Sowden JE, Henderson D, Messing S, Cruttenden K, Schifitto G

Neurology.. 2006 March 2866 (6):857-61. Epub 1900 01 01.

Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster.

Katz J, McDermott MP, Cooper EM, Walther RR, Sweeney EW, Dworkin RH

The journal of pain.. 2005 December 6 (12):782-90. Epub 1900 01 01.

Mood fluctuations in Parkinson's disease: a pilot study comparing the effects of intravenous and oral levodopa administration.

Richard IH, Frank S, Ladonna KA, Wang H, McDermott MP, Kurlan R

Neuropsychiatric disease and treatment.. 2005 September 1 (3):261-8. Epub 1900 01 01.

The prevalence of PD in a nutritionally deficient rural population in China.

Zhang L, Nie ZY, Liu Y, Chen W, Xin SM, Sun XD, Fan JH, Liu YH, Gao XH, Lu LQ, Como P, McDermott MP, Qiao YL, Kieburtz K

Acta neurologica Scandinavica.. 2005 July 112 (1):29-35. Epub 1900 01 01.

The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.

Hu Y, McDermott MP, Ahrendt SA

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2005 April 111 (7):2502-9. Epub 1900 01 01.

Markers of immune activation and viral load in HIV-associated sensory neuropathy.

Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, McClernon DR, Conant K, Cohen B, Epstein LG, Kieburtz K,

Neurology.. 2005 March 864 (5):842-8. Epub 1900 01 01.

Establishment of an alternative intracellular cytokine staining assay for HIV/AIDS clinical studies.

Chen H, Reichman R, Keefer M, McDermott MP, Jin X

Journal of virological methods.. 2005 February 123 (2):131-40. Epub 1900 01 01.

Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.

Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Rudolph A, Lang AE,

Neurology.. 2005 January 1164 (1):87-93. Epub 1900 01 01.

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J,

Pain.. 2005 January 113 (1-2):9-19. Epub 1900 01 01.

Order-restricted inference for the scale-like inverse Gaussian parameters.

Natarajan R; Mudholkar GS; McDermott MP.

Journal of Statistical Planning and Inference. 2005; 127(1-2): 229-236.

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, Marder K

Neurology.. 2004 December 1463 (11):2084-90. Epub 1900 01 01.

The ups and downs of Parkinson disease: a prospective study of mood and anxiety fluctuations.

Richard IH, Frank S, McDermott MP, Wang H, Justus AW, Ladonna KA, Kurlan R

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.. 2004 December 17 (4):201-7. Epub 1900 01 01.

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert SM, Kieburtz K, deMarcaida JA, Cohen B, Epstein LG

Archives of neurology.. 2004 November 61 (11):1687-96. Epub 1900 01 01.

Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7).

Hall CB, Caserta MT, Schnabel KC, Boettrich C, McDermott MP, Lofthus GK, Carnahan JA, Dewhurst S

The Journal of pediatrics.. 2004 October 145 (4):472-7. Epub 1900 01 01.

Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children.

Caserta MT, McDermott MP, Dewhurst S, Schnabel K, Carnahan JA, Gilbert L, Lathan G, Lofthus GK, Hall CB

The Journal of pediatrics.. 2004 October 145 (4):478-84. Epub 1900 01 01.

Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis.

Neurology.. 2004 August 2463 (4):718-20. Epub 1900 01 01.

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A,

Archives of neurology.. 2004 July 61 (7):1044-53. Epub 1900 01 01.

Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy.

Herrmann DN, McDermott MP, Henderson D, Chen L, Akowuah K, Schifitto G,

Muscle & nerve.. 2004 March 29 (3):420-7. Epub 1900 01 01.

Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study.

Aylward EH, Rosenblatt A, Field K, Yallapragada V, Kieburtz K, McDermott M, Raymond LA, Almqvist EW, Hayden M, Ross CA

Brain research bulletin.. 2003 December 1562 (2):137-41. Epub 1900 01 01.

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.

Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J

Pain.. 2003 December 106 (3):337-345. Epub 1900 01 01.

A controlled trial of rotigotine monotherapy in early Parkinson's disease.

Archives of neurology.. 2003 December 60 (12):1721-8. Epub 1900 01 01.

Cognitive fatigue during a test requiring sustained attention: a pilot study.

Schwid SR, Tyler CM, Scheid EA, Weinstein A, Goodman AD, McDermott MP

Multiple sclerosis : clinical and laboratory research.. 2003 October 9 (5):503-8. Epub 1900 01 01.

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.

Ahrendt SA, Hu Y, Buta M, McDermott MP, Benoit N, Yang SC, Wu L, Sidransky D

Journal of the National Cancer Institute.. 2003 July 295 (13):961-70. Epub 1900 01 01.

Development and testing of the Parkinson's disease quality of life scale.

Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J,

Movement disorders : official journal of the Movement Disorder Society.. 2003 June 18 (6):637-45. Epub 1900 01 01.

Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment.

Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG

Neurology.. 2003 May 1360 (9):1467-73. Epub 1900 01 01.

Predicting verbal memory decline following anterior temporal lobectomy (ATL).

Stroup E, Langfitt J, Berg M, McDermott M, Pilcher W, Como P

Neurology.. 2003 April 2260 (8):1266-73. Epub 1900 01 01.

Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial.

Guttuso T, Kurlan R, McDermott MP, Kieburtz K

Obstetrics and gynecology.. 2003 February 101 (2):337-45. Epub 1900 01 01.

Chronic stress in nonelderly caregivers: psychological, endocrine and immune implications.

Vedhara K, McDermott MP, Evans TG, Treanor JJ, Plummer S, Tallon D, Cruttenden KA, Schifitto G

Journal of psychosomatic research.. 2002 December 53 (6):1153-61. Epub 1900 01 01.

Design and analysis of two-period studies of potentially disease-modifying treatments.

McDermott MP, Hall WJ, Oakes D, Eberly S

Controlled clinical trials. 2002 December 23 (6):635-49. Epub 1900 01 01.

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.

Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM,

Neurology.. 2002 November 2659 (10):1568-73. Epub 1900 01 01.

The value of patient-reported health status in predicting short-term outcomes after coronary artery bypass graft surgery.

Curtis LH, Phelps CE, McDermott MP, Rubin HR

Medical care.. 2002 November 40 (11):1090-100. Epub 1900 01 01.

The behavioral spectrum of tic disorders: a community-based study.

Kurlan R, Como PG, Miller B, Palumbo D, Deeley C, Andresen EM, Eapen S, McDermott MP

Neurology.. 2002 August 1359 (3):414-20. Epub 1900 01 01.

Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.

Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I,

Movement disorders : official journal of the Movement Disorder Society.. 2002 July 17 (4):758-63. Epub 1900 01 01.

Incidence of and risk factors for HIV-associated distal sensory polyneuropathy.

Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, Epstein L, Kieburtz K,

Neurology.. 2002 June 2558 (12):1764-8. Epub 1900 01 01.

Quantitative functional measures in MS: what is a reliable change?

Schwid SR, Goodman AD, McDermott MP, Bever CF, Cook SD

Neurology.. 2002 April 2358 (8):1294-6. Epub 1900 01 01.

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.

JAMA.. 2002 April 3287 (13):1653-61. Epub 1900 01 01.

HIV-associated cognitive impairment before and after the advent of combination therapy.

Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L

Journal of neurovirology.. 2002 April 8 (2):136-42. Epub 1900 01 01.

Treatment of ADHD in children with tics: a randomized controlled trial.

Neurology.. 2002 February 2658 (4):527-36. Epub 1900 01 01.

Construction of uniformly more powerful tests for hypotheses about linear inequalities.

McDermott MP; Wang Y.

Journal of Statistical Planning and Inference. 2002; 107(1-2): 207-217.

Combining dependent p-values.

Kost JT; McDermott MP.

Statistics and Probability Letters. 2002; 60(2): 183-190.

Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.

Neurology.. 2001 November 1357 (9):1566-70. Epub 1900 01 01.

Prevalence of tics in schoolchildren and association with placement in special education.

Kurlan R, McDermott MP, Deeley C, Como PG, Brower C, Eapen S, Andresen EM, Miller B

Neurology.. 2001 October 2357 (8):1383-8. Epub 1900 01 01.

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.

Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R,

Neurology.. 2001 October 2357 (8):1434-40. Epub 1900 01 01.

Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease.

Archives of neurology.. 2001 October 58 (10):1660-8. Epub 1900 01 01.

A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.

Neurology.. 2001 August 1457 (3):397-404. Epub 1900 01 01.

A prospective natural history study of inclusion body myositis: implications for clinical trials.

Rose MR, McDermott MP, Thornton CA, Palenski C, Martens WB, Griggs RC

Neurology.. 2001 August 1457 (3):548-50. Epub 1900 01 01.

Freezing of gait in PD: prospective assessment in the DATATOP cohort.

Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, Tanner C,

Neurology.. 2001 June 2656 (12):1712-21. Epub 1900 01 01.

Expression of Fas (CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival.

Papathanassoglou ED, Moynihan JA, McDermott MP, Ackerman MH

Critical care medicine.. 2001 April 29 (4):709-18. Epub 1900 01 01.

Factors associated with incident human immunodeficiency virus-dementia.

Stern Y, McDermott MP, Albert S, Palumbo D, Selnes OA, McArthur J, Sacktor N, Schifitto G, Kieburtz K, Epstein L, Marder KS,

Archives of neurology.. 2001 March 58 (3):473-9. Epub 1900 01 01.

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.

Shoulson I, Penney J, McDermott M, Schwid S, Kayson E, Chase T, Fahn S, Greenamyre JT, Lang A, Siderowf A, Pearson N, Harrison M, Rost E, Colcher A, Lloyd M, Matthews M, Pahwa R, McGuire D, Lew MF, Schuman S, Marek K, Broshjeit S, Factor S, Brown D, Feigin A, Mazurkiewicz J, Ford B, Jennings D, Dilllon S, Comella C, Blasucci L, Janko K, Shulman L, Wiener W, Bateman-Rodriguez D, Carrion A, Suchowersky O, Lafontaine AL, Pantella C, Siemers E, Belden J, Davies R, Lannon M, Grimes D, Gray P, Martin W, Kennedy L, Adler C, Newman S, Hammerstad J, Stone C, Lewitt P, Bardram K, Mistura K, Miyasaki J, Johnston L, Cha JH, Tennis M, Panniset M, Hall J, Tetrud J, Friedlander J, Hauser R, Gauger L, Rodnitzky R, Deleo A, Dobson J, Seeberger L, Dingmann C, Tarsy D, Ryan P, Elmer L, Ruzicka D, Stacy M, Brewer M, Locke B, Baker D, Casaceli C, Day D, Florack M, Hodgeman K, Laroia N, Nobel R, Orme C, Rexo L, Rothenburgh K, Sulimowicz K, Watts A, Wratni E, Tariot P, Cox C, Leventhal C, Alderfer V, Craun AM, Frey J, McCree L, McDermott J, Cooper J, Holdich T, Read B,

Neurology.. 2001 February 2756 (4):455-62. Epub 1900 01 01.

Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes.

Schifitto G, Kieburtz K, McDermott MP, McArthur J, Marder K, Sacktor N, Palumbo D, Selnes O, Stern Y, Epstein L, Albert S

Neurology.. 2001 February 1356 (3):415-8. Epub 1900 01 01.

Uniformly more powerful tests for hypotheses about linear inequalities when the variance is unknown. (PDF)

Wang Y; McDermott MP.

Proceedings of the American Mathematical Society. 2001; 129(10): 3091-3100.

A multiple sclerosis cluster associated with a small, north-central Illinois community.

Schiffer RB, McDermott MP, Copley C

Archives of environmental health.. 2001 56 (5):389-95. Epub 1900 01 01.

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

JAMA.. 2000 October 18284 (15):1931-8. Epub 1900 01 01.

Release of the neuronal glycoprotein ICAM-5 in serum after hypoxic-ischemic injury.

Guo H, Tong N, Turner T, Epstein LG, McDermott MP, Kilgannon P, Gelbard HA

Annals of neurology.. 2000 October 48 (4):590-602. Epub 1900 01 01.

Soluble fas levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients.

Papathanassoglou ED, Moynihan JA, Vermillion DL, McDermott MP, Ackerman MH

Shock.. 2000 August 14 (2):107-12. Epub 1900 01 01.

Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1-infected individuals: relationship to TH1 and TH2 cytokine profile.

Schifitto G, McDermott MP, Evans T, Fitzgerald T, Schwimmer J, Demeter L, Kieburtz K

Archives of neurology.. 2000 July 57 (7):1027-32. Epub 1900 01 01.

A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD. Parkinson Study Group.

Neurology.. 2000 April 2554 (8):1583-8. Epub 1900 01 01.

The evolution of diagnosis in early Parkinson disease. Parkinson Study Group.

Jankovic J, Rajput AH, McDermott MP, Perl DP

Archives of neurology.. 2000 March 57 (3):369-72. Epub 1900 01 01.

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC, Kieburtz K

Neurology.. 2000 January 1154 (1):233-5. Epub 1900 01 01.

Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis.

Tawil R, McDermott MP, Brown R, Shapiro BC, Ptacek LJ, McManis PG, Dalakas MC, Spector SA, Mendell JR, Hahn AF, Griggs RC

Annals of neurology.. 2000 January 47 (1):46-53. Epub 1900 01 01.

A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group.

Clinical neuropharmacology.. 2000 23 (1):34-44. Epub 1900 01 01.

Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy.

Dreyer K, Kallas EG, Planelles V, Montefiori D, McDermott MP, Hasan MS, Evans TG

AIDS research and human retroviruses.. 1999 November 2015 (17):1563-71. Epub 1900 01 01.

Quantitative assessment of motor fatigue and strength in MS.

Schwid SR, Thornton CA, Pandya S, Manzur KL, Sanjak M, Petrie MD, McDermott MP, Goodman AD

Neurology.. 1999 September 1153 (4):743-50. Epub 1900 01 01.

Higher-moment approaches to approximate interval estimation for a certain intraclass correlation coefficient.

Zou KH, McDermott MP

Statistics in medicine.. 1999 August 1518 (15):2051-61. Epub 1900 01 01.

Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia.

Amin SB, Sinkin RA, McDermott MP, Kendig JW

Archives of pediatrics & adolescent medicine.. 1999 August 153 (8):795-800. Epub 1900 01 01.

Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.

Schifitto G, Sacktor N, Marder K, McDermott MP, McArthur JC, Kieburtz K, Small S, Epstein LG

Neurology.. 1999 July 2253 (2):391-6. Epub 1900 01 01.

Short-term versus longer term pimozide therapy in Tourette's syndrome: a preliminary study.

Neurology.. 1999 March 1052 (4):874-7. Epub 1900 01 01.

Neuropsychologic status in multiple sclerosis after treatment with glatiramer.

Weinstein A, Schwid SR, Schiffer RB, McDermott MP, Giang DW, Goodman AD, Schwid SI

Archives of neurology.. 1999 March 56 (3):319-24. Epub 1900 01 01.

Generalized orthogonal contrast tests for homogeneity of ordered means.

McDermott MP.

Canadian Journal of Statistics. 1999; 27(3): 457-470.

Comment on `The Emperor's New Tests' by MD Perlman and L Wu.

McDermott MP; Wang Y.

Statistical Science. 1999; 14(4): 374-377.

Disease progression in HIV-positive women with moderate to severe immunosuppression: the role of depression. Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders.

Vedhara K, Schifitto G, McDermott M

Behavioral medicine.. 1999 25 (1):43-7. Epub 1900 01 01.

The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease. Parkinson Study Group.

Clinical neuropharmacology.. 1999 22 (4):220-5. Epub 1900 01 01.

Selecting a generic measure of health-related quality of life for use among older adults. A comparison of candidate instruments.

Andresen EM, Rothenberg BM, Panzer R, Katz P, McDermott MP

Evaluation & the health professions.. 1998 June 21 (2):244-64. Epub 1900 01 01.

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.

Growdon JH, Kieburtz K, McDermott MP, Panisset M, Friedman JH

Neurology.. 1998 May 50 (5):1327-31. Epub 1900 01 01.

Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R

Neurology.. 1998 May 50 (5):1402-6. Epub 1900 01 01.

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

Neurology.. 1998 March 50 (3):645-51. Epub 1900 01 01.

Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995.

Holloway RG, Witter DM, Mushlin AI, Lawton KB, McDermott MP, Samsa GP

Archives of neurology.. 1998 January 55 (1):25-32. Epub 1900 01 01.

Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study Group.

Carter JH, Stewart BJ, Archbold PG, Inoue I, Jaglin J, Lannon M, Rost-Ruffner E, Tennis M, McDermott MP, Amyot D, Barter R, Cornelius L, Demong C, Dobson J, Duff J, Erickson J, Gardiner N, Gauger L, Gray P, Kanigan B, Kiryluk B, Lewis P, Mistura K, Malapira T, Zoog K

Movement disorders : official journal of the Movement Disorder Society.. 1998 January 13 (1):20-8. Epub 1900 01 01.

Conditional likelihood ratio test for a nonnegative normal mean vector. (PDF)

Wang Y; McDermott MP.

Journal of the American Statistical Association. 1998; 93(441): 380-386.

A conditional test for a nonnegative mean vector based on a Hotelling's T2-type statistic. (PDF)

Wang Y; McDermott MP.

Journal of Multivariate Analysis. 1998; 66(1): 64-70.

The role of multifamily therapy in promoting retention in treatment of alcohol and cocaine dependence.

Conner KR, Shea RR, McDermott MP, Grolling R, Tocco RV, Baciewicz G

The American journal on addictions. 1998 7 (1):61-73. Epub 1900 01 01.

The measurement of ambulatory impairment in multiple sclerosis.

Schwid SR, Goodman AD, Mattson DH, Mihai C, Donohoe KM, Petrie MD, Scheid EA, Dudman JT, McDermott MP

Neurology.. 1997 November 49 (5):1419-24. Epub 1900 01 01.

Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients. Parkinson Study Group.

Annals of neurology.. 1997 November 42 (5):747-55. Epub 1900 01 01.

Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group.

JAMA.. 1997 July 9278 (2):125-30. Epub 1900 01 01.

Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

Neurology.. 1997 July 49 (1):142-6. Epub 1900 01 01.

A controlled trial of fluoxetine in nondepressed patients with Huntington's disease.

Como PG, Rubin AJ, O'Brien CF, Lawler K, Hickey C, Rubin AE, Henderson R, McDermott MP, McDermott M, Steinberg K, Shoulson I

Movement disorders : official journal of the Movement Disorder Society.. 1997 May 12 (3):397-401. Epub 1900 01 01.

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis.

Schwid SR, Petrie MD, McDermott MP, Tierney DS, Mason DH, Goodman AD

Neurology.. 1997 April 48 (4):817-21. Epub 1900 01 01.

A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.

Neurology.. 1997 January 48 (1):38-46. Epub 1900 01 01.

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC

Neurology.. 1997 January 48 (1):46-9. Epub 1900 01 01.

Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders.

Neurology.. 1996 November 47 (5):1247-53. Epub 1900 01 01.

Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis.

Schwid SR, Goodman AD, Puzas JE, McDermott MP, Mattson DH

Archives of neurology.. 1996 August 53 (8):753-7. Epub 1900 01 01.

Effect of lazabemide on the progression of disability in early Parkinson's disease. The Parkinson Study Group.

Annals of neurology.. 1996 July 40 (1):99-107. Epub 1900 01 01.

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.

Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D

Annals of neurology.. 1996 June 39 (6):744-8. Epub 1900 01 01.

A controlled trial of remacemide hydrochloride in Huntington's disease.

Kieburtz K, Feigin A, McDermott M, Como P, Abwender D, Zimmerman C, Hickey C, Orme C, Claude K, Sotack J, Greenamyre JT, Dunn C, Shoulson I

Movement disorders : official journal of the Movement Disorder Society.. 1996 May 11 (3):273-7. Epub 1900 01 01.

Clinical research in neurology. From observation to experimentation.

Marshall FJ, Kieburtz K, McDermott M, Kurlan R, Shoulson I

Neurologic clinics.. 1996 May 14 (2):451-66. Epub 1900 01 01.

A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder.

Feigin A, Kurlan R, McDermott MP, Beach J, Dimitsopulos T, Brower CA, Chapieski L, Trinidad K, Como P, Jankovic J

Neurology.. 1996 April 46 (4):965-8. Epub 1900 01 01.

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group.

Annals of neurology.. 1996 January 39 (1):29-36. Epub 1900 01 01.

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.

Annals of neurology.. 1996 January 39 (1):37-45. Epub 1900 01 01.

Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus.

Gumbiner B, Wendel JA, McDermott MP

The American journal of clinical nutrition.. 1996 January 63 (1):110-5. Epub 1900 01 01.

Effects of exposure to dietary nickel and zinc upon experimental allergic encephalomyelitis in SWXJ mice.

Schiffer RB; Baggs RB; McDermott MP.

Journal of Trace Elements in Experimental Medicine. 1996; 9(1): 1-9.

Psychological characteristics of MS patients: determining differences based upon participation in a therapy regimen.

Armer JM; McDermott MP; Schiffer RB.

Rehabilitation Nursing Research. 1996; 5(3): 102-111.

Non-obscene complex socially inappropriate behavior in Tourette's syndrome.

Kurlan R, Daragjati C, Como PG, McDermott MP, Trinidad KS, Roddy S, Brower CA, Robertson MM

The Journal of neuropsychiatry and clinical neurosciences.. 1996 8 (3):311-7. Epub 1900 01 01.

Multiple sclerosis. Sexual dysfunction and its response to medications.

Mattson D, Petrie M, Srivastava DK, McDermott M

Archives of neurology.. 1995 September 52 (9):862-8. Epub 1900 01 01.

Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.

McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW

Archives of neurology.. 1995 June 52 (6):565-70. Epub 1900 01 01.

Robust finite-intersection tests for homogeneity of ordered variances. (PDF)

Mudholkar GS; McDermott MP; Mudholkar A.

Journal of Statistical Planning Inference. 1995; 43(1-2): 185-195.

Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation. FSH-DY Group.

Griggs RC, Tawil R, McDermott M, Forrester J, Figlewicz D, Weiffenbach B

Muscle & nerve. Supplement. 1995 2 :S50-5. Epub 1900 01 01.

Bilineal transmission in Tourette's syndrome families.

Kurlan R, Eapen V, Stern J, McDermott MP, Robertson MM

Neurology.. 1994 December 44 (12):2336-42. Epub 1900 01 01.

Comparison of posthospital survival after acute myocardial infarction in women and men.

Gottlieb S, Moss AJ, McDermott M, Eberly S

The American journal of cardiology.. 1994 October 174 (7):727-30. Epub 1900 01 01.

The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group.

Kieburtz K, McDermott M, Como P, Growdon J, Brady J, Carter J, Huber S, Kanigan B, Landow E, Rudolph A

Neurology.. 1994 September 44 (9):1756-9. Epub 1900 01 01.

Cigarette smoking and the age at onset of a first non-fatal myocardial infarction.

Gottlieb S, Fallavollita J, McDermott M, Brown M, Eberly S, Moss AJ

Coronary artery disease.. 1994 August 5 (8):687-94. Epub 1900 01 01.

A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease. Parkinson Study Group.

Archives of neurology.. 1994 April 51 (4):342-7. Epub 1900 01 01.

Tourette's syndrome in a special education population: a pilot study involving a single school district.

Kurlan R, Whitmore D, Irvine C, McDermott MP, Como PG

Neurology.. 1994 April 44 (4):699-702. Epub 1900 01 01.

Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Personius KE, Pandya S, King WM, Tawil R, McDermott MP

Physical therapy.. 1994 March 74 (3):253-63. Epub 1900 01 01.

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group.

Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC

Neurology.. 1994 March 44 (3 Pt 1):442-6. Epub 1900 01 01.

Levodopa drug holiday versus drug dosage reduction in Parkinson's disease.

Kurlan R; Tanner CM; Goetz C; Sutton J; Lichter D; Carvey P; Deeley C; Cui L; Irvine C; McDermott MP.

Clin Neuropharmacol. 1994; 17(2): 117-127.

A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome.

Kurlan R, Como PG, Deeley C, McDermott M, McDermott MP

Clinical neuropharmacology.. 1993 April 16 (2):167-72. Epub 1900 01 01.

A controlled trial of lazabemide (RO19-6327) in untreated Parkinson's disease. Parkinson Study Group.

Annals of neurology.. 1993 April 33 (4):350-6. Epub 1900 01 01.

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.

The New England journal of medicine.. 1993 January 21328 (3):176-83. Epub 1900 01 01.

Developing a stable bilateral model of parkinsonism in rhesus monkeys.

Smith RD, Zhang Z, Kurlan R, McDermott M, Gash DM

Neuroscience.. 1993 January 52 (1):7-16. Epub 1900 01 01.

Use of compliance measures in an analysis of the effect of diltiazem on mortality and reinfarction after myocardial infarction.

Oakes D; Moss AJ; Fleiss JL; Bigger JT Jr; Therneau T; Eberly SW; McDermott MP; Manatunga A; Carleen E; Benhorin J; the Multicenter Diltiazem Post-Infarction Trial Research Group.

J Am Statist Assoc. 1993; 88(421): 44-49.

Testing homogeneity of ordered variances.

Mudholkar GS; McDermott MP; Aumont J.

Metrika. 1993; 40(1): 271-281.

A simple approach to testing homogeneity of order constrained means.

McDermott MP; Mudholkar GS.

J Am Statist Assoc. 1993; 88(424): 1371-1379.

Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group.

LeWitt PA, Galloway MP, Matson W, Milbury P, McDermott M, Srivastava DK, Oakes D

Neurology.. 1992 November 42 (11):2111-7. Epub 1900 01 01.

Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid.

Metras JI, Swenson CF, McDermott MP

American journal of hospital pharmacy. 1992 July 49 (7):1720-4. Epub 1900 01 01.

Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction.

Gottlieb S, Moss AJ, McDermott M, Eberly S

The American journal of cardiology.. 1992 April 1569 (12):977-84. Epub 1900 01 01.

Living alone after myocardial infarction. Impact on prognosis.

Case RB, Moss AJ, Case N, McDermott M, Eberly S

JAMA.. 1992 267 (4):515-9. Epub 1900 01 01.

Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group.

Moss AJ, Oakes D, Rubison M, McDermott M, Carleen E, Eberly S, Brown M

The American journal of cardiology.. 1991 August 1568 (5):429-33. Epub 1900 01 01.

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.

Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I

Neurology.. 1990 October 40 (10):1529-34. Epub 1900 01 01.

Effect of deprenyl on the progression of disability in early Parkinson's disease.

The New England journal of medicine.. 1989 November 16321 (20):1364-71. Epub 1900 01 01.

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group.

Archives of neurology.. 1989 October 46 (10):1052-60. Epub 1900 01 01.

A class of tests for equality of ordered means.

Mudholkar GS; McDermott MP.

Biometrika. 1989; 76(1): 161-168.

The effect of diltiazem on mortality and reinfarction after myocardial infarction.

The New England journal of medicine.. 1988 August 18319 (7):385-92. Epub 1900 01 01.

Evaluation by enzyme-linked immunosorbent assay of local and systemic production of milk immunoglobulins to surface exopolysaccharide antigen in cows with staphylococcal mastitis.

Loeffler DA, McDermott MP, Norcross NL

The Cornell veterinarian.. 1987 October 77 (4):293-302. Epub 1900 01 01.

Books

Clinical Trials in Neurology: Design, Conduct, Analysis (2012)

Chapter: Two period designs for evaluation of disease-modifying treatments

Authors: McDermott MP

Publisher: Cambridge University Press, Cambridge 2012

Clinical Trials in Neurology: Design, Conduct, Analysis (2012)

Authors: Ravina B, Cummings J, McDermott MP, Poole M (eds)

Publisher: Cambridge University Press, Cambridge 2012

Journal of Statistical Planning and Inference (2007)

Chapter: Life and Legacy of Samarendra Nath Roy 1906-1964

Authors: Mudholkar GS, McDermott MP, Hutson AD

Publisher: Elsevier Science 2007

Recent Advances in Clinical Neurophysiology (1996)

Chapter: Implications of Molecular Defects for Classification and Treatment of Periodic Paralysis

Authors: Griggs RC, Tawil R, Brown RH Jr, Shapiro BE, Ptacek LJ, McManis PG, Dalakas MC, Mendell JR, Hahn AF, McDermott MP, the Working Group on Periodic Paralysis

Publisher: Elsevier Science, New York 1996

Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders (1993)

Chapter: Rating Tic Severity

Authors: Kurlan R; McDermott MP

Publisher: Marcel Dekker, New York 1993